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CHAPTER 1:  INTRODUCTION 
Fractures are the most common and most expensive of nonfatal fall-related 
injuries.  According to the Center for Disease Control, the economic burden placed on 
the 2012 American healthcare system by fractures was $18.8 billion and is expected to 
increase to over $40 billion by 2020 [1].  Although women account for only 58% of 
individuals older than 65, they are 2.3 times more likely to experience a fracture and 
treatment is 2.8 times more expensive than men [2].  Interventions that can identify 
potential fractures will significantly reduce health care costs and improve quality of life 
for the increasing number of elderly individuals.   
Osteoporosis is a skeletal disorder that results with a weakening of bones and 
increases the risk of fracture [3, 4].  The most common method of diagnosing 
osteoporosis is by measuring the bone mineral density (BMD) of a few critical skeletal 
sites, (i.e. femoral neck, distal radius, and 4 lumbar vertebra).  A dual-energy x-ray 
absorptiometry (DXA) test is widely used to derive the areal BMD of individual skeletal 
sites and compare those values to the ideal BMD of a healthy 30-year-old adult.  A 
diagnosis of osteoporosis is given if the BMD of any site is less than 2.5 standard 
deviations from this norm [5].   
However, skeletal sites throughout the body have different rates of bone 
turnover causing some to decrease faster than others [6].  For decades, authors have 
theorized that the rate of bone mineral remodeling was determined by the proportion 
of surface area to bone volume present in each bone [7, 8].  Therefore, a sudden bone 
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afflicting stimulus would affect the cancellous BMD prior to the cortical bone.  It is in 
these highly cancellous bone regions where fracture risk could be expected to occur.  
Therefore, a diagnosis of osteoporosis at one site may not correlate to another site.  For 
example, Kanis et al. noted that in a 100 subject group, 14% were given a diagnosis of 
osteoporosis at either the distal radius or lumbar spine while only 3% were seen with a 
diagnosis at both sites [9].   
1.1. Rational for skeletal heterogeneity 
There are 206 bones in the average adult skeleton and each bone is unique in 
terms of function, structure, and composition.  The minerals that constitute the osseous 
tissue of these bones are continually being remodeled; however, the rate at which 
different sites remodel may vary throughout the skeleton.  Bergmann et al. attempted 
to assess the heterogeneity of skeletal-wide bone remodeling by measuring the 
concentrations of Calcium-47 throughout the whole body [10].  However, they were 
unable to separate adjacent skeletal regions due to technical limitations.  Although 
some studies have suspected skeletal-wide inhomogeneity, none have separated 
cortical from cancellous BMD. 
A suggested cause of differences in bone remodeling between skeletal sites was 
recently explained as an ‘epigenetic postcode’ [11].  This genetic sequence enables cells 
to retain their origin and/or body positioning information, which permits separate bone 
cell populations to be regulated autonomously.   While the study only investigated 
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epigenetic postcode from two specific sites, it suggests an epigenetic postcode exists for 
each bone.  If different skeletal sites remodel differently based on an epigenetic 
postcode, then measuring the cancellous tissue through bone mineral density (BMD) 
should be able to show the differences throughout the body. 
In order to understand the range and depth of skeletal heterogeneity and the 
effects of cancer treatment, it is necessary to utilize different models of capturing 
natural bone heterogeneity.  Several methods of assessment are needed which have 
been not been developed previously.  By developing these modalities, we provide 
means to assess skeletal-wide heterogeneity in terms of bone mineral density, 
trabecular bone matrix characteristics, and bone marrow content.  Pre-clinical models 
allow us to study mammals in a controlled environment while mimicking treatment 
effects and investigating responses longitudinally.  With clinical trials, we can verify pre-
clinical results and draw conclusions regarding treatment intervention and the impact 
on skeletal heterogeneity. 
1.2. Methods of assessment for murine and human skeleton 
Recent technological advancements in in vivo imaging for the pre-clinical model 
has made longitudinal studies of the murine skeleton possible.  For this work we used 
the Siemens Inveon® PET/CT.  Although this is a commercially available machine, there 
have been few publications on its utility or characterization.  Therefore, work needed to 
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be done to identify strengths of the machine as well as find optimal configurations for 
our longitudinal studies with the mouse model.   
As mentioned above, DXA is the most common modality used for assessing bone 
health in the general human population.  However, it has several limitations which make 
DXA’s use over the whole body inaccurate and misrepresentative.  First, DXA calculates 
the areal BMD of individual skeletal sites using two dimensional imaging, see Figure 
1-1a.  Two dimensional imaging cannot separate skeletal sites that overlap each other or 
extra osseous tissue.  Therefore, bones of the thoracic spine may overlap with the 
sternum or ribs or contents in the digestive system.  Second, it superimposes the dense 
outer cortical bone and the porous internal cancellous bone.  This can mask the true 
condition of cancellous bone.  Finally, marrow composition can vary the density of the 
whole bone from site to site causing differences between bones.  Therefore, a 
technique is needed that can separate cortical bone from cancellous bone throughout 
the whole skeleton.  Although conventional (i.e. single-energy) computed tomography 
(CT) (Figure 1-1b) can produce 3D images, it cannot differentiate different bone marrow 
compositions. 
However, current methods of quantifying marrow fat (e.g. transiliac biopsy) are 
inaccurate, invasive, and not-repeatable or, as previously mentioned, and use MRI 
which is expensive and has limited availability.  Therefore, it would be optimal to 
employ a technique that could utilize CT modalities, which are already commonly 
employed in cancer treatment centers, to monitor bone marrow health.   
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Figure 1-1.  Representative images from clinical whole body scanners.  A. DXA scan - 
notice 2D image superimposes sternum, ribs, and digestion organs over vertebral 
column.  Subject is also post left hip replacement.   B. CT scan – 3D imaging allows 
individual analysis of each skeletal site as well as separation of cancellous bone from 
cortical bone. 
 
Water-fat MRI (wfMRI) could also measure volumetric marrow composition [12].  
However, MRI use is limited in cancer patients after diagnosis, perhaps due to its high 
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cost and/or limited availability in some locations. Newly developed technology has 
reduced the radiation dose to patients and improved imaging quality of DECT [13]. Thus, 
DECT is frequently performed to diagnose and monitor cancer. 
However, DECT has never been used to assess the entire mammal skeleton, 
much less that of a human.  If the entire body can be imaged volumetrically and 
corrected for marrow content, it would be possible to quantify accurate BMD for all 
skeletal sites.  This would be the first step in finding correlations between an individual 
skeletal site parameters and fracture incidence.   
1.3. Importance of marrow fat assessment 
Bone marrow occupies the space between the trabecular bone matrix and 
represents 80% of cancellous bone.  Red marrow is more hematopoietically active and 
denser than yellow marrow (1.030 and 0.980 g/cm3, respectively).  The conversion of 
bone marrow from red marrow to yellow marrow is well known to occur as one ages 
and can undergo reconversion to red marrow during times of physiologic stress [14-16] 
(Figure 1-2).  Thus, the physical density of marrow can vary depending on the 
concentration of red and yellow marrow [17, 18].   
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Figure 1-2. Diagrammatic representation of distribution of red and yellow marrow from 
birth to age 25 years.  Taken from Kricun et al. [16]. 
 
Although this change is normal as one ages, increased marrow fat can affect the 
observed BMD of common clinical tools (i.e. DXA).  As Blake et al. has demonstrated, the 
observed difference in density between 100% yellow marrow and 0% yellow marrow for 
DXA BMD was estimated to be 0.14g/cm2 for women [19].  This difference may seem 
insignificant, however, it should be concerning since trabecular bone varies by a small 
range, 1.0 – 1.2 g/cm3 [20]. Therefore, changes in marrow composition may confound 
true changes in cancellous BMD if the two types of marrow are not distinguished [21]. 
Dual energy CT (DECT) uses differential attenuation from two energies for marrow 
 8 
 
correction [22], see Figure 1-3.   Details of the dual energy decomposition model will be 
described in Chapter 3. 
 
Figure 1-3. Difference in CT# for identical material using dual energy. 
 
It has been shown that increased marrow fat, even when age-corrected, is highly 
associated with osteoporosis [23, 24]. Yellow marrow fat cells (i.e. adipocytes) are 
derived from mesenchymal stem cells (MSC) which are non-hematopoietic, pluripotent 
marrow progenitor cells.  These cells can differentiate primarily into either osteoblasts 
or adipocytes. Under the influence of radiotherapy or chemotherapy, MSC demonstrate 
enhanced commitment to adipogenesis [25, 26], resulting in reduced osteogenic 
potential [27] and increased MF.  
Increased marrow fat at certain locations is becoming an important biomarker 
for bone health.  Schellinger et al. has also shown that the ratio of marrow fat to BMD 
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significantly increases the ability to assess the weakening of bone compared to either 
individually (p = 0.02) [28]. Cytotoxic treatments such as therapeutic radiation or 
chemotherapy can increase the risk of osteoporosis with one of the first signs being 
increased marrow fat [29, 30].  Cancer treatment induces large changes in marrow 
composition [31-33]. 
 
1.4. Outline of this document 
This dissertation follows this outline: 
Chapter 2 introduces the modality of micro-Computed Tomography (µCT) and 
the work done to characterize the machine for assessment of trabecular bone in the 
murine model.  Trabecular bone is studied specifically to describe localized parameters 
and also to assess the heterogeneity of bone mineral density throughout the entire 
skeleton.  The ideal parameters needed to be identified for imaging the trabecular bone 
while preventing an excessive radiation dose for µCT.  With this optimization, it is 
possible to quantify trabecular parameters and monitor changes longitudinally.  Future 
work is highlighted and describes the potential of dual isotope micro-PET/CT to identify 
longitudinal changes due to cytotoxic treatment in both calcified bone tissue and bone 
marrow.  This can be performed in order to assess changes in both compartments 
throughout the entire skeleton. 
The work described in Chapter 3 assesses longitudinal changes in bone health 
due to cancer treatment in the human body.  29 women were enrolled in a clinical trial 
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which followed them for 1 year after diagnosis of a cancer of the reproductive system 
(i.e. ovarian, endometrial, or cervical cancer).  Treatment for all women included 
bilateral salpingo-oophorectomy; however, 17 were further treated with chemotherapy 
and/or localized radiation therapy.  Several imaging modalities were used to assess 
skeletal health including dual energy absorptiometry (DXA), dual energy computed 
tomography (DECT), and water-fat magnetic resonance imaging (wfMRI).  Results with 
both DECT and wfMRI show an increase in marrow fat production for patients who 
underwent chemotherapy and radiation compared to those who underwent 
oophorectomy alone. 
The data presented in Chapter 4 offers a validation of in vivo clinical imaging by 
correlating the modalities of wfMRI and DECT with co-registered histologic analysis.  
Recently expired human donors were imaged with both modalities and the lumbar 
spinal column was excised.  The midsections of 21 vertebral bodies were processed for 
H&E histology.  The ratio of adipose tissue to total tissue volume in the histologic slides 
is compared to the signal fat fraction intensities of both imaging modalities.  A good 
correlation (r> 0.75) for both wfMRI and DECT is seen when they were compared with 
each other and with results from histology. 
Chapter 5 describes the first assessment of the entire human body using dual 
energy CT for cancellous bone heterogeneity.  10 control and 10 cancer-treated donors 
are examined with DECT shortly after death and imaged from head to toe.  23 major 
trabecular bone sites are examined and marrow-corrected BMD (mcBMD) values are 
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compared across the entire skeleton.  Trabecular bone is shown to vary from site to site 
showing heterogeneity throughout the entire body.  Correlations between the mcBMD 
of different skeletal sites show that some sites can be used as a better estimate of 
trabecular mcBMD than others.  However, cancer treatment disrupts these relationships 
as seen by a loss of average correlation between skeletal sites.   
Chapter 6 lists general conclusions and summaries are given from this 
dissertation.  Future research that could be performed following this work is discussed 
for both clinical and pre-clinical studies. 
1.5. Scientific output in this dissertation 
1.5.1. Journal Publications 
a) Arentsen, L., Hui, S. (2013). Characterization of Rotating Gantry microCT 
configuration for the In Vivo Evaluation of Murine Trabecular Bone.  Microscopy 
& Microanalysis. 
b) Bolan, P., Arentsen, L., Sueblinvong, T., Zhang, Y., Moeller, S., Carter, J., Downs, 
L., Ghebre, R., Yee, D., Froelich, J., & Hui, S. (2013). Water-Fat MR Imaging for 
Assessing Changes in Bone Marrow Composition due to Radiation and 
chemotherapy in Gynecologic Cancer patients.  Journal of Magnetic Resonance 
Imaging.  
c) Chityala, R., Pudipeddi, S., Arentsen, L., Hui, S. (2012). Segmentation and 
Visualization of a Large, High-Resolution Micro-CT Data of Mice. Journal of 
Digital Imaging, 1-7.  
 12 
 
d) Yagi, M., Arentsen, L., Shanley, R., Sharkey, L., Kidder, L., White, M., Ogawa, K., 
Rosen, C., Yee, D., Hui, S. (2014). A dual isotope hybrid whole body micro-PET/CT 
system reveals functional heterogeneity and early local and systemic changes 
following targeted radiation to the murine caudal skeleton. Calcified Tissue 
International.  
e) Arentsen, L., Yagi, M., Takahashi, Y., Shanley, R., Hansen, K., McArthur, A., Yee, 
D., Hui, S. In Situ assessment reveals skeletal-wide heterogeneity of human 
cancellous bone using dual energy computed tomography. Submitted to 
Osteoporosis International.  
f) Arentsen, L., Yagi, M., Takahashi, Y., White, M., Bolan, P., Hui, S. Validation of 
marrow fat assessment using noninvasive imaging with histologic examination of 
human bone samples. Submitted to Bone. 
1.5.2. Conference Presentations 
a) Yagi, M., Arentsen, L., Takahashi, Y., Sharkey, L., Koizumi, M., Xian, C., Rosen, C., 
Yee, D., Hui, S. (December 2013). A Dual isotope hybrid µCT-PET system reveals 
functional heterogeneity of bone lining cells and longitudinal changes in marrow 
from local radiation and chemotherapy.  Presented at 99thAnnual Radiologic 
Society of North America Meeting: Chicago, IL. Available at 
http://rsna2013.rsna.org/program/?PAGE=1# (SSQ12-06). Accessed June 13th, 
2014. 
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b) Arentsen, L., Brown, K., Bolan, P., Thanasak Sueblinvong, Shanley, R., Ghebre, 
RG., Minenko, AG., Grammens, G., Lee, C., Yan Zhang, Le, C., Froelich, J., Downs, 
L., Yee, L., Hui, S. (October 2013). Multimodality Imaging to measure and map 
treatment effect on marrow fat distribution and it’s relation with BMD: Results 
of a pilot study in cancer survivors. Presented at 35th Annual American Society of 
Bone and Mineral Research meeting, Baltimore, MD. Abstract in J Bone Miner 
Res 28 (Suppl 1).  Available at 
http://www.asbmr.org/education/AbstractDetail?aid=8812c94a-30d8-4b58-
91a4-8fd63c8f03c5.  Accessed June 13th, 2014. 
c) Yagi, M., Arentsen, L., Takahashi, Y., Sharkey, L., Koizumi, M., Xian, C., Rosen, C., 
Yee, D., Hui, S. (October 2013). A Dual isotope hybrid µCT-PET System Reveals 
Functional heterogeneity of bone lining cells and longitudinal Changes in Marrow 
from Local radiation and chemotherapy. Presented at 35th Annual American 
Society of Bone and Mineral Research meeting: Baltimore, MD. Abstract in J 
Bone Miner Res 28 (Suppl 1).  Available at 
http://www.asbmr.org/education/AbstractDetail?aid=3828c732-3919-4b9d-
8e9c-42370a777a74.  Accessed June 13th, 2014. 
d) Hui, S., Arentsen, L., Sueblinvong, T., Downs, L., Potter, D., Grammens, G., 
Ghebre, R., Allen, S., Minenko, A., Zhang, Y., Le, C., Froelich, J., Jackson, G., 
Bhattacharyya, M., Yee, D. (October 2013). A Novel 41Ca Assay to measure short 
and long-term mineral kinetics in patients undergoing cancer therapy.  Presented 
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at 35th Annual American Society of Bone and Mineral Research meeting: 
Baltimore, MD. Abstract in J Bone Miner Res 28 (Suppl 1).  Available at 
http://www.asbmr.org/education/AbstractDetail?aid=4eb83fcc-01bf-4a88-b685-
950fc4a5e360. Accessed June 13th, 2014. 
e) Arentsen, L., Hui, S. (October 2013). Multimodality imaging to measure and map 
treatment effect on marrow fat distribution and it’s relation with BMD. 
Presented at 4th Annual Masonic Cancer Center research Symposium: 
Minneapolis, MN. 
f) Arentsen, L., Brown, K., Bolan, P., Thanasak Sueblinvong, Shanley, R., Ghebre, 
RG., Minenko, AG., Grammens, G., Lee, C., Yan Zhang, Le, C., Froelich, J., Downs, 
L., Yee, L., Hui, S. (September 2013). Multimodality Imaging to measure and map 
treatment effect on marrow fat distribution and it’s relation with BMD: Results 
of a pilot study in cancer survivors. Presented at Annual Clinical and Translational 
Science Institute Meeting, Minneapolis, MN.  
g) Yagi. M., Arentsen, L., Hui, S. (August 2013). Early Time effect of local radiation 
on entire normal bone marrow. Presented at 55th Annual American Association 
of Physicists in Medicine Meeting: Indianapolis, IN.   
h) Yagi. M., Arentsen, L., Takahashi, Y., Sharkey, L., Koizumi, M., Xian, C., Yee, D., 
Hui, S. (May 2013). Assessment of functional heterogeneity and longitudinal 
effect of local radiation and chemotherapy on entire skeletal bone and marrow 
using dual isotope hybrid µCT-PET system.  Presented at 2nd Joint Meeting of the 
 15 
 
International bone and Mineral society and the Japanese Society for Bone and 
Mineral Research (IBMS-JSBMR 2013): Kobe, Japan.  
i) Hui, S., Bolan, P., Arentsen, L., Sueblinvong, T., Downs. L., Ghebre, R., Froelich, J., 
Yee, D. (September 2012). Water-Fat MR Imaging for Assessing Therapy-Induced 
Bone Marrow Damage in Gynecological cancers. Presented at Annual Clinical and 
Translational Science Institute Meeting: Minneapolis, MN.  
j) Arentsen, L., Hui, S. (July 2012). Characterization of Rotating-Stage microCT for 
the analysis of trabecular bone in mice. Presented at 54th Annual American 
Association of Physicists in Medicine Meeting: Charlotte, NC. 
k) Arentsen, L., Hui, S. (April 2012). Characterization of Rotating-Stage microCT for 
the analysis of trabecular bone in mice.  Presented at North Central Chapter 
AAPM Semi-annual Meeting (NCCAAPM): Minneapolis, MN. 
l) Arentsen, L., Coghill, K., Fairchild, G., Hui, S. (October 2011). Investigation of 
skeletal heterogeneity & impact on cancer treatment.  Presented at North 
Central Chapter AAPM Semi-annual Meeting (NCCAAPM): Wisconsin Dells, WI. 
m) Arentsen, L., Hui, S. (April 2011). Tracking treatment induced changes in bone 
and marrow using Dual Energy QCT. North Central Chapter AAPM Semi-annual 
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CHAPTER 2:  CHARACTERIZATION OF MICRO-CT FOR THE 
MURINE MODEL AND USE ON LOCALIZED AND WHOLE-BODY 
IMAGING 
2.1. Introduction 
2.1.1. Motivation for whole-body imaging using micro-CT 
With increased cancer survivorship [34], there is an increased and unmet need to 
evaluate treatment-related skeletal damage, including the understanding of 
mechanisms of damage that will lead to preventive strategies. Over the years, Micro-
computed tomography, or micro-CT, has been used for studying bone loss in mice [5-7]. 
Although it is typically used for single micron-level resolution for individual excised 
bones, it can also be used on anesthetized animals.  This would reduce the number of 
mice needed since each mouse could be used as its own control in a longitudinal study.  
The imaging setup for harvested bone is similar to full animal imaging. But, certain 
precautions need to be considered [8] in full animal imaging.  As we’ve shown 
previously, the dose to the live animal has to be increased as the resolution increases. 
This puts a limit on the resolution, especially when one attempts to image the entire 
skeleton.   
Despite these constraints, full animal imaging has been conducted and described 
in historical literature [11-12]. Granton et al. [13] have demonstrated rapid imaging of 
rats using cone-beam micro-CT to measure non-invasively whole-body adipose tissue 
volume (ATV), lean tissue volume (LTV), skeletal tissue volume (STV), and bone mineral 
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content (BMC). Although the whole body was imaged, their resolution was 486 x 160 x 
880, much smaller compared to our data set of 2048 x 2048 x 6300, a difference of two 
orders of magnitude. Such large datasets present problems in computation and 
visualization since the file sizes are so large (i.e. approximately 60 GB). 
Although the results presented here are for imaging of sacrificed mice, the 
protocol is being developed with in-vivo imaging of live animals in mind. 
2.1.2. Rationale for the characterization of rotating gantry micro-CT for in vivo 
imaging  
Micro-CT has become a useful imaging modality for investigations in a multitude 
of disciplines.  Areas of application can range from material science [35] to the study of 
human pathologies in small animal models [36].  Micro-CT is desirable to illustrate small 
animal anatomy because of its non-destructive acquisition [37, 38].  There currently 
exist two main configurations for commercially available micro-CT systems: a fixed 
source and detector combination with a rotating sample or a fixed sample with a 
rotating source and detector[39].  The latter is preferable for in vivo imaging since the 
specimen can be affixed to the sample holder in a horizontal position.  Before whole 
body imaging can be performed, micro-CT must first be characterized in order to assess 
both regional changes in cancellous bone and skeletal changes.   
It has been shown that slight physical parameter changes of the micro-CT can 
drastically affect the resulting image quality [40, 41].  When high-resolution images are 
needed for the analysis of detailed anatomy (e.g., trabecular bone) physical parameters 
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must be precisely appointed.  It is even more crucial to establish these parameters when 
investigating changes to live specimens over time.  Images must be taken with limited 
dose and a short acquisition time to minimize the amount of anesthesia required.   
The goal of this work is to characterize the rotating gantry micro-CT modality for 
in vivo small animal trabecular bone imaging and use it to assess BMD throughout the 
entire murine skeleton.  This is done using the physical parameters of magnification, 
binning, filtration thickness, peak energy, and soft tissue thickness.   
Table 2-1 summarizes the physical parameters that are tested to characterize the 
rotating gantry µCT.    
 
Magnification Binning 
Energy 
(kVp) 
Filter 
Thickness 
(mmAl) 
Phantom 
Magnification  
1.3x, 1.8x, 
3.3x 
2 80 0.5 3 
Binning 3.3x 1, 2, 4  80 0.5 3 
Peak Energy 3.3x 2 
80, 70, 
60, 50, 
40 
0.5 1 
Filtration 3.3x 2 80, 40 
0.0, 0.5, 
1.0, 1.5 
1 
Tissue 
thickness 
3.3x 2 80, 40 0.5 2 
 
Table 2-1. Table of experimental parameters.  Phantom 1: Density-equivalent material; 
Phantom 2: 7mL Water and 7mL Butanol tubes; and Phantom 3: A micro-CT wire 
phantom.  All scans performed with manufacture-recommended calibrations.  Exposure 
times are determined by peak within 75-85% CCD range 
  
 19 
 
Experiments involve altering the beam geometry and quantization, through 
magnification and binning, and the average energy through filtration and peak energy.  
In general, physical magnification is varied for the rotating gantry µCT configuration by 
changing the distances between the x-ray source and the sample being imaged.  Binning 
is the averaging of local voxels into one ‘super voxel’.   
The energy of the acquisition beam can be directly modified by altering the 
electric potential, i.e. peak energy (kVp) across the source.  When filtration is added to a 
polychromatic radiation beam, the probability of a photoelectric interactions increases 
by 1/E3 (where E is the energy of the incident photon).  In other words, adding filtration 
attenuates lower energy photons more resulting in a higher average energy beam [42, 
43].  Similarly, increasing the thickness of the surrounding tissue will preferentially 
attenuate more of the radiation beam’s lower energy photons. Reducing lower energy 
photons in the acquisition beam is beneficial to in vivo experiments because lower 
energy photons are mostly attenuated by the specimen and only increase absorbed 
dose [44].  As well, without low energy photon attenuation many artifacts such as 
cupping, streaks, and flair artifacts that prevent accurate BMD estimation would occur 
[45].   
Similar to beam filtration, increasing the thickness surrounding a ROI causes 
more low energy photons to be attenuated before reaching the detector.   To reduce 
the standard deviation of regions of interest, it is preferable to scan anatomy with less 
tissue thickness such as the distal humerus or proximal tibia.  These locations are 
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imaged best when the appendage is stretched from underneath the body to beside the 
head or tail.  This will reduce the amount of tissue surrounding the region of interest as 
seen by a decreasing standard deviation.   
In longitudinal studies, a small animal may undergo body mass changes that can 
increase the tissue surrounding regions of interest such as bone [46].  Also, at different 
skeletal locations between different species of small animals, the surrounding tissue can 
be quite different.  Thus, more tissue implies an increased amount of absorption of 
lower energy photons. The beam parameters were selected from guidelines for micro-
CT imaging set forth by Bouxsein et al. [47].  Different parameter combinations are 
measured in terms of Hounsfield Units for a uniform region of interest (ROI).   
Image acquisitions of the left distal femur of mice are taken to assess the effects 
these physical parameters have on dose, scan time, and trabecular microstructure 
estimation.  The objective is to describe the optimal rotating gantry micro-CT acquisition 
protocol for imaging microscopic skeletal anatomy of mice in vivo.   
2.2. Methods 
This study utilized a commercially available Siemens Inveon Micro-CT (Siemens 
Medical Solutions USA Inc. Molecular Imaging, USA).  The system was equipped with a 
165 mm detector with a field of 4,064 x 4,064 pixels and a dynamic range of 67dB for 
Bin1 to 84dB for Bin4.  A description of binning is provided below.  Recent publications 
have assessed the physical parameters of the Inveon micro-PET and micro-SPECT  
modalities [48].  However, after reviewing the published literature, no characterization 
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of the Inveon MM µCT modality for the in vivo examination of mouse trabecular bone 
could be found.   
Hounsfield Unit (HU) values for different density equivalent materials were 
evaluated using the Inveon Research Workstation (IRW) Version 3.0 (Siemens Molecular 
imaging, Germany) and ImageJ Version 1.44 [49].  All scanning protocols employed the 
maximum current available, 500 µA.  Exposure time was modified according to the 
recommendations of the manufacturer.  To keep the experiment constant, each 
scanning protocol captures 180 images over a single 360 degree rotation.  Manufacture-
recommended calibrations were implemented for every scanning protocol.  These 
included the center-offset calibration and the HU scale calibration.  The HU calibration 
was performed whenever a change in parameters affects the geometrical magnification, 
x-ray voltage, or x-ray filter thickness.  The reconstruction protocols for all parameter 
tests employed the same Shepp-Logan reconstruction filter as well as utilizing the 
Bilinear Interpolation method.  A polynomial-based soft tissue beam hardening 
correction employing coefficient values commonly used for scanning the average mouse 
was also used for reconstructing all images. 
Three types of calibration phantoms were used to characterize the Inveon micro-
CT.   
 Phantom 1: A Siemens-provided density equivalent cylinder made of Lucite 
that has six holes drilled axially as seen in Figure 2-1.  Rods of different 
densities were inserted into 4 of the hollow cylinders to represent the typical 
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density diversity found in the bone and soft tissue of small animals [50].   The 
densities include: 1.750 g/cm3, 1.250 g/cm3, 1.050 g/cm3, and 1.000 g/cm3 
with the other two holes empty to simulate an air-equivalent density.  The 
surrounding lucite has a density of 1.040 g/cm3.   
 
Figure 2-1. Phantom 1:  3D reconstruction of density phantom with 6 densities: 1.750 
g/cm3, 1.250 g/cm3, 1.050 g/cm3, 1.000 g/cm3, and two air-equivalent densities.  The 
surrounding Lucite material has a density of 1.040 g/cc. 
 Phantom 2: Two 7 mL polyethylene tubes scanned individually; one filled 
with Type 1 deionized water (1.00 g/cm3) and the other with laboratory 
grade butanol (0.781 g/cm3).  The liquids can be used to theoretically 
approximate the average density of the two types of bone marrow (1.030 
g/cm3 for red marrow and 0.98 g/cm3 for yellow marrow).   
 Phantom 3: A micro-CT wire phantom produced by Quality Assurance in 
Radiology and Medicine (QRM) GmbH (Moehrendorf, Germany) was scanned 
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to determine spatial resolution (line pairs/mm).  A 10 µm tungsten wire is 
suspended in air along the central axis of a sturdy resin cylinder.  They 
cylinder was scanned along the central axis of the micro-CT rotating gantry.  
After a line spread function was integrated from a small region of interest 
surrounding the wire, the 10% Modulation Transfer Function (MTF) was 
assessed similar to previous work [51]. 
2.2.1. Beam Geometry  
Three Source-to-Axis Distances (SAD) and Source-to-Detector Distances (SDD) 
were used to alter magnification of the system.  This changed the resolution of the 
images as quantified by a change in effective pixel size.  The magnification was altered 
from 3.3x (100.8 mm SAD, 333.8 mm SDD) for high magnification, to 1.8x (183.6 mm 
SAD, 320.5 mm SDD), and 1.3x (263.6 mm SAD, 336 mm SDD) for medium and low 
resolution, respectively.  The scan protocols were set up in series so that no external 
intervention would alter the position or orientation of Phantom 3 in between 
magnification changes.  The three options for the Inveon MM µCT scanner are no 
binning, or Bin1, a binning of 2, or of 4.  Bin2 is the average of 4 neighboring voxels into 
1 voxel while bin4 takes the average of 16 neighboring voxels.  The images for Phantom 
3 were taken at 80 kVp energy with a 0.5 mmAl filter and a magnification of 100 mm 
SAD.  The detector consists of pixels that are spaced 32 µm apart and when using 80 kVp 
and 500 µA a nominal focal-spot size of approximately 60 µm is produced.  MTF 
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measurements were performed for the nine parameter combinations and the spatial 
resolution at 10% was evaluated [52].  
2.2.2. Beam Energy 
To characterize the effect of the x-ray beam’s peak energy, five different kVp 
acquisition beams were used to image Phantom 1.  The beams ranged from an electric 
potential of 40 kVp to 80 kVp at increments of 10 kVp.  All five beams had a 0.5 mmAl 
filter, a current of 500 µA, and a binning of 2.  The acquisition time was increased as 
peak kilovoltage decreased.  For example, exposure time ranged from 750 msec to 
3,000 msec for 80 and 40 kVp, respectively.  The ROIs used to analyze each density 
cylinder of Phantom 1 were equal in dimensions with a volume of 1.5 mm3.   
Four filter thicknesses were investigated: 0.0 mmAl (no filtration), 0.5 mmAl, 1.0 
mmAl, and 1.5 mmAl.  The Inveon MM µCT does have a built in Beryllium window that is 
0.254 mm thick; however it afforded a negligible intrinsic beam hardening effect.  Image 
acquisitions at 40 and 80 kVp, bin2, and 100 mm SAD were performed at four filtration 
thicknesses to scan Phantom 1.   
To assess the effect of beam hardening caused by tissue increase, three sheets of 
Superflab bolus material (Radiation Products Design, INC. Minnesota, USA) were used: 
no bolus, 2 mm bolus, and 5 mm.  Each sheet was cut so that it could wrap around a 
Phantom 2 tube without overlap.  This arrangement allows for a beam hardening test 
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due to the beam attenuation in tissue.  All scans were performed using identical 
acquisition and reconstruction protocols.   
2.2.3. Localized In Vivo imaging  
Four healthy, adult mice were affixed to a carbon fiber loading plank in the prone 
position.  The left leg was stretched inferiorly so that the femoral axis was 
approximately aligned to the axis of the rotating gantry.  The left, distal femur was 
examined for trabecular bone microstructure using the 3D Analysis Tool on the IRW 
system.  The analysis volume was held constant between 0.3 mm and 1.0 mm from the 
growth plate in the femoral metaphysis. Previous studies have used this ROI to examine 
trabecular bone changes in small animal studies [53].  To qualitatively evaluate image 
quality, each mouse was scanned at one of four binning and magnification combinations 
to represent the range available on a typical rotating gantry micro-CT (Table 2-2).  The 
total exposure time was about 34 seconds for low resolution images and increased to 
over 126 seconds for high resolution images.  This was due to the increased exposure 
time per projection required to increase the photon count for the detector.  The 
difference in acquisition time for Table 2-2 was due to the warm up calibration that 
should be performed before every acquisition with higher resolution images taking 2.6 
times longer.  This increases the detector reliability and can be performed immediately 
prior to in vivo studies (i.e. before placement of animal specimen).   
  
 26 
 
Isotropic Pixel Size (µm) 9.19 18.4 36.78 95.4 
Magnification 3.3x 3.3x 3.3x 1.3x 
Binning 1 2 4 4 
10% MTF (line pair/mm) 11.76 8.85 4.36 2.51 
BMD estimation (mg/cc) 1585 1556 1443 1384 
BV/TV estimation (%) 9% 16% 19% 43% 
SNR (Mean/SD) 1.66 4.21 6.93 19.2 
Acquisition Time (min:sec) 13:26 10:24 5:19 5:17 
Radiation Dose (cGy) 125.7 117.3 31.9 †4.0 
Total Exposure Time (s) 126 139 36.0 34.2 
Table 2-2. Results of four magnification and binning combinations.  10% MTF Spatial 
Resolution (lp/mm), Bone Mineral Density (BMD) estimation, Bone Volume to Total 
Volume ratio (BV/TV), Signal-to-Noise Ratio (SNR), and Edge definition indicate optimal 
setup at 3.3x magnification with a binning of 2 (18.39 µm isotropic pixel size).   
 
The amount of radiation absorbed is also a criterion for assessing optimal 
scanning parameters when imaging in vivo samples.  Dose to the specimen due to CT 
exposure is influenced by resolution, beam energy, and SNR.  As Equation 2-1 shows, 
increasing the SNR will cause an increase in dose while resolution and slice thickness 
have an inverse effect on dose.   
    
  
   
  
Equation 2-1. Estimating patient dose where D is dose, a is a constant, s is the SNR, e is 
the spatial resolution, and b is the slice thickness. 
 
Dose can also be assessed by examining the coefficient of variation in the linear 
attenuation coefficient of a material as developed by Ford et al. [54], specifically relating 
the effect of altering the voxel size as seen in Equation 2-2.   
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Equation 2-2. Fractional coefficient of variation relative to the linear attenuation 
coefficient of water, 
 
 
.  Δx is isotropic voxel spacing and D is dose. 
 
They propose that to keep the coefficient of variation (i.e. image quality) 
constant but decrease the isotropic pixel size from 90 to 9µm, the dose will need 
increase by 104.  Combining signals from neighboring CCD detector elements increases 
the slice thickness, thus decreasing the dose.  The decrease in SNR due to increasing 
magnification is explained by beam divergence. As the number of detector CCD 
elements increases to accommodate a magnified image, more photons are required for 
them to activate.  As Thurner et al. has described, binning will also reduce the noise of 
the image [55].  Another effect of binning is reduced acquisition and exposure times 
since it requires less photon interactions.  Acquisition time, or the time taken from 
initiation of the protocol to the last projection image prior to reconstruction, also 
decreases as pixels are binned together. It is important to reduce the acquisition time to 
as small as possible to minimize the time for the animal to twitch and to limit the 
amount of anesthesia.   
To accurately assess the radiation dose to the bone, an incision was made on the 
left leg of four mice. Micro-TLDs (Radiation Products Design, Inc., Albertville, MN, USA), 
sealed in plastic to protect from bodily fluids, were used to measure dose due to 
imaging parameters.  Two micro-TLDs were then inserted anterior and posterior to the 
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femur to assess an average dose to bone. The incision was then stitched back together 
using 6-0 surgical thread.  The same four magnification and binning protocols were used 
to scan the mice to assess the changes the protocols have on dose absorption.  An 80 
kVp beam with 0.5 mmAl filter was held constant for all scans while exposure time was 
modified according to manufacturer recommendations.  After 24 hours post imaging, 
the microTLDs were read on a Harshaw TLD Model 5000 reader (Thermo Fisher 
Scientific, Inc., Waltham, MA, USA). 
2.2.4. Methodology for whole-body imaging 
Three healthy Balb/C mice of approximately 15 weeks in age were sacrificed 
using gas asphyxiation and placed in a 40C refrigerator for 4 to 30 hours.  Individually, 
each mouse was removed from the refrigerator and affixed to a thin, concave, 
carbonate plank in a prone position.  The arms were stretched superior and legs 
stretched inferior.  Effort was placed in ensuring that the spine was centered and as 
straight as possible throughout the whole body.  The plank with mouse was inserted 
into the micro-CT loading bay.  Scout views were taken to verify correct position and 
selection of scan distance.  
An x-ray technique of 80 kVp energy, 500 µA current, and an exposure time of 
750 ms were used to image each mouse. The micro-CT scanner was set to a 3.3x 
magnification.  The reconstructed image slices were 2048 x 2048 pixels (37.66 mm x 
37.66 mm) in the trans-axial dimension. The dataset was comprised of more than 6,000 
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axial slices with a total length of 113 mm. Four different couch positions were needed in 
order to scan the entire 20-gram carcass.  At a projection angular interval of 2 degrees, 
four rotations produced 720 projection images.  Axial overlap of 20% was stitched 
together for each rotation to make the final image.   
The Hounsfield unit (HU) was calibrated using a 50 mL centrifuge tube filled with 
de-ionized water, using the scanning setting that was the same as the mouse scan. The 
Hounsfield unit was calculated using equation:  
 

HU
water 
water
1000  (Equation 2-3) 
where  is the attenuation coefficient. 
For calibrating BMD, Phantom 1 was scanned with the same protocol as the mice 
scans.  The image of the bars was reconstructed and calibrated to HU. The resulting HU 
values for each bar were then used to determine the HU-to-BMD conversion formula 
[Figure 2-9].  
2.2.4.1. Visualization  
The first step in determining the BMD was to segment the bone from the rest of 
the mice data [Figure 2-2]. Since there are large numbers of slices, the Renyi entropy 
method was used for segmentation. The algorithm was implemented in Matlab R2011a 
from Mathworks Inc. Adaptive local Renyi entropy (ALREP) method was employed by 
Ravishankar Chityala, PhD of the Minnesota Supercomputing Institute [56, 57]. The 
process is described below. 
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For each image 
a) Perform Global Renyi entropy and determine the threshold (also called 
global renyi threshold). 
b) Divide the image in to multiple blocks 
c) For each block, determine if there are significant number of pixels in that 
block that have pixel values greater than the global renyi threshold.  
d) In each of the block that was marked as containing significant number of 
pixels, perform local Renyi Entropy based thresholding. 
e) Assemble the individual blocks to obtain the complete segmented image. 
f) Determine the BMD value for the segmented regions using the 
relationship established by the method described in the previous section. 
 
 
Figure 2-2. Comparison of a region-of-interest of the 1000th slice. (Left) Original image 
(Center) Global Renyi Entropy (GREP) (Right) ALREP method. Note that the GREP 
method resulted in over-segmentation (shown by arrows), causing fine gaps (marrow) 
to be either filled in comparison to the original image. 
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Manual segmentation was performed to compare the quality of the segmented 
results from ALREP.  For each data set, 60 slices (approximately 10% of the slices) were 
considered.  These slices were segmented by manually thresholding using Avizo [58].  
The threshold was chosen such that the bone region was completely segmented. BMD 
of the segmented region was calculated by implementing the calibration equation 
derived from Phantom 1.  This program identified only the regions corresponding to the 
bone in the original slice data using the bone location in the manually segmented 
images.  The mean value of BMD in the bone region was then calculated.  
Avizo was used for visualization. Since the server had large memory, the entire 
dataset (50GB in size, approximately) was read completely to memory to perform iso-
surface rendering [Figure 2-3]. 
 
Figure 2-3. Reconstruction of whole body mouse image acquisition.  First visualization of 
high resolution (Isotropic pixel size = 9.19µm; > 6,300 slices) micro-CT dataset. 
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2.3. Results 
2.3.1. Beam Geometry 
The physical parameters used to alter spatial resolution were binning and 
magnification.  They can alter isotropic, or nominal, pixel sizes from 9.19µm for a bin1 
and 1.3x to 95µm using Bin4 with 3.3x magnification.  The 10% MTF spatial resolution at 
the 9.19µm isotropic pixel size resulted with 11.8 lp/mm and with 2.5 lp/mm at 95 µm.  
As magnification increased, the spatial resolution increased if binning was held at 2.  For 
3.3x, 1.8x, and 1.3x the 10% MTF were 8.9 lp/mm, 5.3 lp/mm, and 3.4 lp/mm, 
respectively.  As the magnification decreased the Signal-to-Noise Ratio (SNR) increased 
as well.   With all other variables remaining constant, the SNR increased from 4.2 at 1.3x 
to 9.0 and 13.0 at 1.8x and 3.3x, respectively.   
The standard deviation of pixel values drastically decreased as binning increased 
from 724 HU at bin1 to 260 HU at bin2 at 1.750 g/cm3 equivalent density material.  Scan 
time took as long as 13.4 min at Bin1 to 10.4 min to 5.3 min at Bin2 and Bin4, 
respectively.  For image sets with equivalent axial and transaxial lengths, the file sizes 
decrease in size from 2.35 GB to 296 MB to 40 MB for Bin1, Bin2, and Bin4 respectively.  
2.3.2. Beam Energy 
Figure 2-4 shows that as peak energy increases, HU values for 1.750 g/cm3 
equivalent material decreases at a rate of nearly -290 HU/kVp.   
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Figure 2-4. Difference in HU of Phantom 1 with change in Energy.  Notice at lower 
energies the difference between low and high densities is greater. 
 
At 1.250 g/cm3 the HU values decreased as energy increased but at a lesser rate, 
-83 HU/kVp.  Similarly, it is shown in Figure 2-5 that as beam filtration increased the 
difference in HU between water and bone-equivalent densities (e.g. 1.750 g/cm3) 
decreased.  The effect was not as noticeable when the energy of the beam was 
decreased to 40 kVp.  The standard deviation of pixel values between different energies 
or filtrations remained constant.  Therefore, SNR decreased when the peak energy or 
the filtration thickness increased.   
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Figure 2-5. Filtration effect for different densities.  All curves produced with 80 kVp 
energy except for labeled 40 kVp.  Notice as filtration thickness increases, discernment 
between water and 1.750 g/cm3 density decreases.  HU values for 1.750 g/cm3 using 40 
kVp remain relatively constant as thickness increases; however, exposure time 
increases.   
Under identical acquisition parameters, increasing the sample thickness caused 
increased pixel value standard deviation at the center for both liquid compositions in 
Phantom 2.  The minimum standard deviation, 161 HU, was observed when no bolus 
surrounded Phantom 2.   Standard deviation increased to 200.1 HU and 231.6 HU after a 
2 mm and 5 mm sample thickness was added, respectively.  The average HU value for 
water and butanol remained constant for all tissue thickness escalations.   
2.3.3. Localized In Vivo Model 
Scanning the in vivo models at four different binning and magnifications changes 
the isotropic pixel sizes to 9.19 µm, 18.39 µm, 36.78 µm, and 95.39 µm as presented in 
Table 2-2.  As spatial resolution increased, or the nominal pixel size decreased, the Bone 
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Volume to Total Volume ratio (BV/TV) estimation increased.  This trend of increasing 
BV/TV with decreasing resolution was observed in other in vivo studies[59].  Conversely, 
Bone Mineral Density (BMD) estimation and absorbed dose decreased when spatial 
resolution was decreased.  Figure 2-6 shows image cross-sections that were taken in the 
plane perpendicular to the axis of the femur at 0.5mm superior to the distal growth 
plate in the femoral metaphysis.   
 
Figure 2-6. Effect of isotropic pixel size on image clarity.  All images were taken 
perpendicular to the femoral axis at 0.5mm from the growth plate using Siemens Inveon 
MicroCT.  A. 9.19 µm, B. 18.39 µm, C. 36.78 µm, and D. 95.39 µm.  Notice increased 
noise in A. but gross loss of detail with C and D.   
 
Although the image appears clearest at 9.19 µm and blurriest at 95 µm nominal 
pixel size the SNR increased from 2 to 19, respectively.  As seen in Table 2-2, a decrease 
in absorbed dose from approximately 125 cGy to 4 cGy was witnessed when resolution 
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decreases for high resolution to low resolution scans, respectively, with a correlation of 
r = 0.973.   
2.3.4. Whole body imaging findings 
The left panel of Figure 2-2 is the 1000th slice of a mice data set. The image has 
been cropped and contrast enhanced to show only the region of data containing the 
mice. The results of ALREP are shown in the right panel of Figure 2-2. The sizes of the 
segmented objects from ALREP very similar to the original data.  
The average BMD value in the ALREP segmented bone region was determined 
and is plotted for all slices in Figure 2-7. The plot contains the results for three different 
mice titled 15-1, 15-4 and 15-5.  The mean value of BMD for the manually segmented 
data for all three cases is also plotted on the same figure.  The BMD for the ALREP is 
plotted with lines while the manually segmented values are plotted with markers at 
each data point. The x-axis is arranged so that the lower numbers are the head and the 
higher numbers are the tail of the mice.  The labels for various regions are also marked 
in the figure. It can be seen that the three curves corresponding to the three mice follow 
similar pattern but with different values for each slice.  
 37 
 
 
Figure 2-7 Average value of the bone mineral density in mg/cc from the segmented 
region determined using ALREP and manual method. The ALREP method results are 
labeled as 15-1 ALREP, 15-4 ALREP and 15-5 ALREP and the data points are connected by 
lines. The manual segmentation results are labeled as 15-1 manual, 15-4 manual and 15-
5 manual and the data points are shown with markers. 
 
In order to visualize the variation in BMD for the same slice across three mice, an 
average and standard deviation plot was created and is shown in Figure 2-8.  The 
average and standard deviation of BMD was calculated across three mice for each slice 
using ALREP.  For a given slice (a vertical line in the plot), the centerline is the average 
BMD value and the standard deviation of BMD flanks either side of the filled area. This 
plot provides a window to the variation of BMD across three mice for the same slice or 
anatomy. As in Figure 2-7, the lower numbers for the x-axis correspond to the head of 
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the mice while the higher numbers correspond to the tail of the mice. The labels for 
various regions are also marked in the figure. 
The BMD calibration was performed based on the process described in section 
2.2.4 and the results are presented in Figure 2-9. The fitted curve has the following 
equation: 
 40.1018*2241.0  HUBMD  (Equation 2-4) 
 
The regression coefficient for the fit was 0.99831. The segmented pixel values (in HU) 
were processed using the above equation to obtain the corresponding BMD value.  
The results are summarized in Table 2-3. The processing time for 6300 slices was 
150 minutes on a dualcore 2.6 GHz processor and 4 GB of RAM. Although manual 
segmentation was performed only for 60 slices, it took 1 minute to process one slice. 
Hence for 6300 slices, it would have consumed around 6300 minutes or 4.4 days. Thus, 
the ALREP method has a speedup of more than 40 times compared to manual 
segmentation.   Also, manual segmentation of such large data set would result in 
significant human error and hence is not a feasible long-term solution. 
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Figure 2-8 Average and standard deviation plot of BMD obtained using ALREP. The 
average and the standard deviation are calculated across the three datasets. The 
centerline is the average BMD and the standard deviation flanks either side of the 
average. 
 
 
 
Figure 2-9 Calibration curve for BMD. The HU of a phantom containing inserts for which 
the value of electron density was known was imaged and the curve was plotted. A 
straight line fit was then performed on the data points. The equation of the fitted line 
and its regression is shown in the plot. 
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Table 2-3 Comparing ALREP and manual method.    
 
ALREP segmentation Manual 
segmentation 
Processing time 
150 minutes 6300 minutes or  
4.4 days 
Speedup compared 
to manual 
segmentation 
42 times - 
Accuracy Accurate 
segmentation due to 
local thresholding 
Over-segmentation 
due to use of a 
single threshold 
 
2.4. Discussion 
2.4.1. Localized in vivo 
Five parameters are examined to investigate the effects of magnification, 
binning, peak kilovoltage, beam filtration, and tissue thickness.  Results were assessed 
by their effect on resolution, SNR, and absorbed dose.  Different magnification and 
binning settings can be combined to produce image sets with different resolutions.  
Figure 2-10 demonstrates different spatial resolutions that can be achieved by the 
Inveon MM micro-CT while also providing a threshold of a 60µm effective pixel size.   
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Figure 2-10. When magnification decreases or binning increases, the spatial resolution 
will decrease.  The dotted line represents a resolution threshold above which have been 
used to image trabecular bone in murine model [60, 61]. Magnification: High (3.3x), 
Medium (1.8x), Low (1.3x) 
Pixel sizes below 60 µm have been used to provide images capable of analyzing 
trabecular bone microarchitecture in a mouse model [59-61].  For the Inveon MM µCT, a 
binning of 4, no matter the magnification, cannot produce a spatial resolution below 
this threshold.  Similarly, a magnification smaller than 1.8x does not produce an 
effective pixel size that can be used to image murine trabecular bone. Therefore, 
imaging protocols using rotating-gantry µCT must have a binning less than 4 and a 
magnification greater than 1.8x to optimally image the trabecular bone of a murine 
model.  
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The apparent HU variations due to changes in beam energy seen at higher 
density material can be explained by the linear attenuation coefficient.  When the 
average energy increases, either by higher peak energy or increased filtration, the 
material’s attenuation coefficient is reduced.  Hounsfield Units are directly proportional 
to the linear attenuation (Equation 2-5).   
    
            
      
 
Equation 2-5.  HU calculation where       and µ(H2O) refer to the linear attenuation 
coefficient of a material and water respectively at a known energy. 
 
Therefore, as energy increases, the densities approach the density of water, the HU 
values decrease as energy increases.   
2.4.2. Whole-body imaging 
A system for segmenting and visualizing large micro-CT data set of mice was 
presented.  The data set is of size 2048 x 2048 x 6300 pixels and around 50GB in size. 
Since the data set is large, it presents considerable challenge. The data was segmented 
to obtain the bone using Adaptive Local Renyi Entropy (ALREP). Manual segmentation 
was performed to study the effectiveness of ALREP. The manual method of 
segmentation took 6300 minutes (approx.) for 6300 slices, while the automated method 
took only 150 minutes, 40 times faster than manual process.  Since a typical desktop 
does not have the capability to read and render large datasets, a new high-end 
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visualization system was used. VirtualGL and Avizo were used for visualization at 12 
frames per second on a 1 Gbits per second network. 
Step c in ALREP method is used to determine if a given block of the image has a 
significant number of pixels. The image was divided into 16 blocks along x and 16 blocks 
along the y-direction. Each block thus has a size of 128 x 128 = 16384 pixels. For the 
analysis, a region was assumed as significant if it had at least 20 pixels with values 
greater than the global renyi threshold. The 20-pixel value is significantly lower than the 
number of pixels in a block. Hence increasing the number from 20 will not make a big 
change in the block significance process. 
2.4.3. Translation significance 
This method can potentially be implemented to study the longitudinal effects of 
cancer treatment on the entire skeleton thereby simulating recently developed 
preclinical [16] and clinical models [17] of cancer survivors’ bone health. Employing 
diagnostic CT using quantitative computed tomography in a clinical model, we have 
demonstrated that patients with ovarian or endometrial cancer experience an 
accelerated and distinct pattern of bone loss from systemic chemotherapy vs. local 
pelvic radiation. Many radiotherapy patients (e.g., head and neck or cervical cancers) 
undergo multiple whole-body PET-CT scans. These CT scans may be used to generate 
regional as well as complete skeletal BMD distribution, thereby providing important 
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information on the heterogeneity of treatment effects following radiation, 
chemotherapeutic, or a combination of treatment modalities.  
2.4.4. Conclusion 
To properly analyze the trabecular bone in mice it is necessary to use parameters 
that will acquire images with both an acceptable resolution and Signal to Noise Ratio 
(SNR).  For live imaging, there is also a priority to reduce absorbed radiation dose and 
shorten the acquisition time.  To assist with dose reduction and increase SNR, the 
sample should be positioned so as to reduce as much extra tissue as possible from the 
field of view.  
In conclusion, the optimal imaging parameters for a rotating gantry micro-CT in 
the assessment of trabecular bone in mice are an 80 kVp beam with a 0.5 mmAl filter 
and magnification of 3.3x with binning of 2.  These parameters result in an isotropic 
pixel size of 18.39 µm that has an acceptable SNR of 4.21 and a spatial resolution of 8.9 
lp/mm.  The 80 kVp energy and 0.5 mmAl filter make the beam optimal by the 
attenuation of low energy photons to reduce dose and moderate the acquisition time.  
This configuration provides quality images that are sufficient for examining longitudinal 
changes in the trabecular bone of mice.  Future work can be done to assess changes in 
the trabecular bone of mice related to cytotoxic interventions (e.g.,  radiation induced 
bone loss). 
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We have developed a method to automatically segment the bone and study its 
mineral density. We have demonstrated using a large data set of size greater than 50GB 
that segmentation can be obtained within 150 minutes. This method has been shown to 
be considerably faster than manual segmentation.  We also demonstrated the use of 
specialized hardware and software for visualization of these data sets.  
2.5. Further direction 
Further work is described in the supplemental data at the end of this 
dissertation.  Studies were performed to measure functional heterogeneity of the 
murine skeletal system and response to chemotherapy and localized radiation exposure.  
Mice were longitudinally examined using micro-CT and micro-PET using dual isotope to 
measure changes to the calcified tissue as well as active bone marrow.   
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CHAPTER 3:  CANCER THERAPY CAUSES RAPID AND 
HETEROGENEOUS EXPANSION OF MARROW FAT AND 
DECREASED BONE MINERAL DENSITY 
3.1. Introduction 
Cancer survivors experience a greater risk of fracture compared to the general 
population [62-66]. However, the effect of cancer treatment, especially the relationship 
between marrow fat (MF) and bone mineral density (BMD), are not well known. 
Mesenchymal stem cells (MSC) are non-hematopoietic, pluripotent marrow progenitor 
cells which give rise primarily to osteoblasts and adipocytes. Under the influence of 
radiotherapy or chemotherapy, MSC demonstrate enhanced commitment to 
adipogenesis [25, 26], resulting in reduced osteogenic potential [27] and increased MF, 
a major source of serum adiponectin. However, changes in MF are not readily detected 
by a traditional dual-emission X-ray absorptiometry (DXA) scan, since DXA only 
calculates average BMD by superimposing cortical and cancellous BMD. We 
demonstrated that radiation-induced increases in MF were not reflected in equivalent 
loss of cancellous bone in ovariectomized compared with intact mice [67].  
Changes in marrow composition can alter determination of BMD as mentioned 
in Section 1.3. The physical density of red marrow is approximately 1.20 g/cm3 
compared with that of yellow marrow (0.98 g/cm3). Since cancellous bone is composed 
mostly of marrow (~80%), changes in marrow composition may confound true changes 
in cancellous BMD if the two types of marrow are not distinguished. Dual energy CT 
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(DECT) uses differential attenuation from two energies for marrow correction [22], but 
has never been translated into osteoporosis clinical care. This may be due to the high 
radiation dose exposure from multiple CT scans using older scanners, or because age-
related osteoporosis typically results in only modest changes in marrow composition. In 
contrast, cancer treatment induces large changes in marrow composition [31-33]. 
Moreover, water-fat MRI (wfMRI) could also measure volumetric marrow composition 
[12].  However, MRI use is limited in cancer patients after diagnosis, perhaps due to its 
high cost and/or limited availability in some locations. Newly developed technology has 
reduced the radiation dose to patients and improved imaging quality of DECT [13]. Thus, 
DECT is frequently performed to diagnose and monitor cancer. We hypothesized that 
DECT and wfMRI could reliably measure changes in MF associated with cancer 
treatments.  
Our overall goal is to develop clinically useful biomarkers to predict, measure, 
and monitor cancer-therapy induced bone loss, thereby individualizing therapy to 
decrease bone morbidity and ultimately enhancing quality of life for cancer survivors. 
The aims of this pilot study were therefore to 1) assess the ability of DECT to quantify 
the effects of cancer treatments on MF and marrow corrected BMD (mcBMD), 2) 
compare information collected by DECT to that collected by WF-MRI and DXA, and 3) 
explore whether serum adiponectin reflected changes in MF associated with cancer 
treatments.  
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3.2. Methods 
3.2.1. Subjects 
Women older than 18 years old with newly diagnosed ovarian and endometrial 
cancer who planned to receive chemotherapy or radiation therapy following 
oophorectomy were eligible for the study. Twelve women with early stage ovarian or 
endometrial cancer who underwent surgical oophorectomy but not adjuvant 
chemotherapy or radiation therapy served as the control group. We excluded women 
with osteoporosis, hyperparathyroidism and those who had received chemotherapy, 
radiation or hormonal therapy within the prior year. The study was approved by the 
University of Minnesota Institutional Review Board (#0906M67981) and complies with 
the World Medical Association Declaration of Helsinki — Ethical Principles for Medical 
Research Involving Human Subjects. 
Twenty-nine patients were recruited for this study. Ovarian cancer patients 
(n=11) were treated with carboplatin and paclitaxel 175 mg/m2 every 21 days for ≥6 
cycles. Endometrial cancer patients (n=6) were primarily treated using external beam 
radiation therapy (EBRT) to the pelvis (median dose, 45-50 cGy in 25-28 fractions) and 
additional radiation at the vaginal surface using high dose rate (HDR) brachytherapy. 
The radiation window encompassed the pelvis up to ~L5.  
Venous blood samples were collected at 0, 6 and 12 months, serum was 
extracted and stored at -800C until analysis. Serum adiponectin was measured using a 
human ELISA kit (R&D Systems Inc., Minneapolis, MN, USA); the lower limit of detection 
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was 0.246 ng/mL and intra and inter-assay coefficients of variation were 2.5-4.7% and 
<7%, respectively. Serum resistin was measured using a human ELISA kit (B-Bridge 
International, Mountain View, CA, USA); the lower limit of detection was 0.2 ng/mL and 
intra and inter-assay coefficients of variation were <5% and <6%, respectively. 
3.2.2. DECT and MR Imaging 
DECT scanning (Somatom Definition Flash, Siemens, Germany) was performed at 
140 and 80 kVp energy in single scan.  Fifteen subjects were imaged at baseline, 6 and 
12 months after treatment. A CT calibration phantom (Mindways Software, Austin, TX) 
commonly used for bone densitometry was positioned under each patient and spanned 
the scanned volume which extended from L3 through the right femoral neck.  QCT Pro 
(Mindways Software, Austin, TX) was used to derive single-energy (140 kVp) volumetric 
BMD estimates. DXA (GE Healthcare Lunar Prodigy, Madison, WI) was also performed at 
0 and 12 months. 
On the same day as DECT imaging, 15 subjects also underwent wfMRI scans at 0, 
6 and 12 months using a 3 T Siemens TRIO scanner (TIM Trio, Siemens, Erlangen, 
Germany). Images were obtained at L1-L5 and the right femoral neck. Detail on the 
wfMRI method is given elsewhere [12]. Briefly, three consecutive 3D images were 
acquired with TR=9 ms, TE=2, 3, and 4 ms, parallel imaging acceleration 3x2, and 
nominal resolution of 1.1 x 1.1 x 2.45 mm. The WF reconstruction was performed using 
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the method of Berglund et al. (20). The 3D fat fraction image was calculated as MF = fat/ 
(fat+water) and exported in DICOM format for analysis.  
For DECT, two different energy CT spectrums (Figure 3-1) can be used for basis 
material composition estimates [68].  Average basis material composition 
(            ) was estimated for an ROI placed within matching regions of in CT data 
sets acquired at 80 kVp and 140 kVp using the following equations: 
       
 
 
                                                    (Equation 3-1) 
          
 
 
                                              (Equation 3-2) 
                                              (Equation 3-3) 
where CT80 and CT140 are the average CT values within the defined ROIs and 
                                         are calibration slopes determined from CT 
calibration phantom measurements.  
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Figure 3-1. Dual energy spectrum used in Siemens SOMATOM ® dual source computed 
tomography scanner.  The difference in energy can be utilized to identify material 
through basis material decomposition.  Image taken from Johnson et al. [69]. 
This can be used to assess bone ROIs relative to the manufacturer-reported basis 
material compositions for the CT calibration phantom[17]. These basis material 
compositions were interpreted relative to water and a theoretical prediction of the basis 
material composition of yellow marrow obtained from energy-dependent mass 
attenuation coefficients calculated using an openly available tool (XCOM) [69, 70], 
atomic composition data from ICRU Publication 46 and a density of 0.93 g/cm3 [71]. 
Patient measurements were projected onto the line in the basis material space 
connecting the basis material composition of yellow marrow and that of water using a 
minimum distance projection, P, parameterized such that the position P=100% 
corresponded to yellow marrow and the position P=0% corresponded to water. The 
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DECT-derived estimate of MF was calculated using: MF = 0.348 * P + 85.7%. We 
performed linear transformation of these DECT fat-fraction estimates to the MRI fat-
fraction scale, taking into account average mcBMD among the study subjects. The 
transformation did not impact measurement correlation, supporting its use in detection 
of longitudinal changes in fat fraction.  
3.2.3. Statistics 
Statistical models were used to evaluate mcBMD and MF trends over time by 
treatment, skeletal region, and imaging modality. Graphical methods such as 
scatterplots and boxplots identified important relationships, such as measurement 
distributions and within-patient correlation over time, which informed analysis 
methods. Linear regression was used to estimate the functional relationship between 
DECT and WF-MRI MF measurements. Differences in MF or mcBMD based on treatment 
or skeletal region were analyzed using generalized estimating equations (GEE*) models 
[72], with each model employing one outcome measured by a single imaging modality. 
Each model had main effects for age, time (0, 6 and 12 months) and treatment (or 
region), an interaction effect of time and treatment (or region) and modeled within-
subject correlation using an exchangeable structure. Wilcoxon signed rank tests were 
applied to evaluate changes over time for individual factor levels, such as a particular 
treatment or skeletal region.  Region models included all patients who received 
oophorectomy, radiation, or chemotherapy, and treatment models use measurements 
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fixed at a single region, either L4 or L5.  Reported p-values were not adjusted for 
multiple testing. Unless otherwise stated, results are in terms of the mean or difference 
in means between groups or times, and differences are given in absolute, not relative, 
units. All analyses were performed using R version 2.10.1.  
3.3. Results 
Table 3-1 summarizes demographic characteristics of all subjects. One patient died 
during the study and thus, results are reported for sixteen subjects with paired data. MF 
was higher by (estimated change ± standard error) 0.32 ± 0.12 absolute percentage 
points for each additional year of age (p=0.005). Likewise, mcBMD was lower by 1.1 ± 
0.3 mg/cm3 for each additional year of age (p<0.001).   
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 Treatment modalities (cancer type) 
Variable Chemotherapy Radiation Therapy Oophorectomy 
Sample Size 11 6 12 
Age, years 55 ± 17 52 ± 7 53 ± 6 
Body Mass Index, kg/m2 27 ± 5 32 ± 6 35 ± 6 
DXA % Fat at baseline 42 ± 8 46 ± 7 48 ± 6 
DXA % Fat at 12 months 43 ± 7 44 ± 10 49 ± 5 
Table 3-1. Demographic Characteristics of Subjects. Data are summarized using the mean ± 
standard deviation. Chemotherapy was the principal treatment modality for ovarian 
cancer, radiation therapy was primarily used to treat endometrial cancer, and 
oophorectomy was performed in early stage ovarian and endometrial cancer patients who 
did not require subsequent radiation or chemotherapy.  
We observed a high overall correlation (r = 0.77, 95% CI: 0.69, 0.83) between 
DECT and WF-MRI based MF quantification at L3, L4, and L5 for 15 subjects (Figure 3-2) 
with r = 0.80 (95% CI: 0.65, 0.89) at baseline; r = 0.68 (95% CI: 0.47, 0.81) at 6 months; r 
= 0.66 (95% CI: 0.44, 0.80) at 12 months. Likewise, changes in MF from 0 to 12 months 
were highly correlated by both imaging methods (r = 0.91, 95% CI: 0.84, 0.95).  
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Figure 3-2. Correlation between DECT and WF-MRI marrow fat (MF) at L3, L4 and L5. A) 
A high correlation (r=0.77, 95% CI: 0.69, 0.83) in MF measurements (includes L3, L4, and 
L5) between the two imaging modalities was observed at baseline (triangle), 6 (circle) 
and 12 months (star) post treatment. B) Measurements of absolute change in MF from 
baseline to 12 months were highly correlated between the two imaging methods (r= 
0.91, 95% CI: 0.84, 0.95). 
 
Figure 3-3 shows the effect of all treatments on individual skeletal regions. At 
baseline, absolute percent difference in MF by DECT (Figure 3-3A) varied. MF in L3 and 
L4 were equivalent, whereas L5 MF was lower by 4% (p<0.001) and FN MF was higher by 
13% (p<0.001), relative to L3 and L4. MF increased in all regions over time (p<0.001), 
with an estimated mean change of 7% from baseline to 12 months. The degree of 
change was similar among the four regions imaged (p=0.27). Using WF-MRI (Figure 
3-3B), MF also increased in all four regions over time (p<0.002). L3-L5 MF increased by 
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15% from baseline to 12 months. The increase in FN MF was approximately half the 
increase of L3-L5 (p=0.025).  
 
Figure 3-3. Region Effects on marrow fat or MF measured by DECT (A) and MRI (B). The 
colored region of each boxplot represents the 1st and 3rd quartile range of observations, 
with a black line at the median. Whisker lines are placed at the 1.5 interquartile range of 
the lower and upper quartile and outliers are noted with open circles. A. DECT: Regions 
differed in mean MF at baseline. L3 and L4 were equivalent, and L5 was lower by 4% 
(p<0.001) and FN higher by 13% (p<0.001) relative to L3 and L4. MF increased over time 
at all sites measured (p<0.001), with an estimated mean change of 7% from baseline to 
12 months for all regions. The degree of change in MF was similar among the four 
regions (p=0.27). B. MRI: Regions differed in mean MF at baseline. L3 and L4 were 
equivalent, L5 was higher by 5%, and FN was higher by 32% (p<0.001). MF increased 
over time at all sites measured (p<0.002), with an estimated mean change of 15% from 
baseline to 12 months for L3-L5. In contrast to DECT, the increase in FN MF was 
approximately half the increase of L3-L5 (p=0.025).   
 
We next measured absolute percent change in MF at L4 and L5 after 
oophorectomy, radiation, and chemotherapy using DECT and WF-MRI (Figure 3-4). The 
majority of radiation treatment was localized to tissues overlying the L5 vertebral body. 
L4 MF by DECT increased by 9% after radiation, 9% after chemotherapy, and 4% after 
oophorectomy (p<0.032). The degree of increase in MF was larger for chemotherapy 
and radiation relative to oophorectomy (interaction p=0.004). Changes in L5 MF by 
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DECT (Figure 3-4B) were similar to those seen in L4, although the radiation group had a 
larger increase in MF at L5. From 0 to 12 months, L5 MF increased by 17% with 
radiation, 8% with chemotherapy and 4% with oophorectomy (p<0.032).  The increase in 
L5 MF was greater for radiation and chemotherapy, relative to oophorectomy 
(interaction p<0.001). Likewise, increased L4 and L5 MF from 0 to 12 months was 
observed by WF-MRI (Figure 3-4C and D). Changes in L4 MF varied by treatment 
(interaction p<0.001), with smallest increases following oophorectomy (6%) compared 
to chemotherapy (24%) or radiation (19%).   
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Figure 3-4. Absolute Percent Change in L4 and L5 Marrow Fat by Treatment.  A & B: 
Based on dual energy computed tomography (DECT) imaging in 15 subjects from 0 to 12 
months, L4 MF increased by 9% after radiation, 9% after chemotherapy, and 4% after 
oophorectomy (p<0.032). The increase in MF was larger for chemotherapy and radiation 
relative to oophorectomy (interaction p=0.004). From 0 to 12 months, L5 MF increased 
by 17% with radiation, 8% with chemotherapy and 4% with oophorectomy (p<0.032). 
The change varied based on treatment (time x treatment interaction p<0.001). C & D: By 
water- fat MRI imaging, L4 and L5 MF increased from 0 to 12 months. The change varied 
based on treatment (time x treatment interaction p<0.001). L4 MF increased by 19% 
after radiation, by 24% after chemotherapy, and by 6% after oophorectomy. Likewise, 
L5 MF by WF-MRI increased from 0 to 12 months. L5 MF increased by 32% after 
radiation, by 18% after chemotherapy, and by 6% after oophorectomy.   
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Mapping of MF distribution was developed using DECT and WF-MRI. Figure 3-5 is 
a representative figure showing longitudinal changes in MF distribution in the spine 
associated with chemotherapy. An increase in MF throughout all marrow regions were 
observed at both 6 and 12 months, long after treatment completion, suggesting 
systemic and sustained increases in MF resulting from chemotherapy. 
 
Figure 3-5. Marrow fat mapping of a representative patient using DECT and water-
fatMRI.  Spine marrow fat mapping: Longitudinal changes in marrow fat distribution in 
spine due to chemotherapy for a representative subject at a) baseline, B) 6 months and 
C) 12 months after treatment using DECT (top figure) and water-fat MRI (bottom figure). 
Changes in MF were visible within 6 months of treatment, and continued to increase at 
12 months.  
 
Figure 3-6 shows absolute differences in mcBMD in mg/cm3 over one year by 
skeletal region, treatment and imaging modality. DECT-derived mcBMD was significantly 
different between skeletal regions (p<0.01), suggesting inherent skeletal heterogeneity 
(Figure 3-6A). 
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Figure 3-6. BMD changes measured by different techniques.  A. DECT mcBMD by skeletal 
regions and time: Regions differed in mean mcBMD at baseline (p<0.001); L4 was higher 
by 12 mg/cm3 and L5 by 25 mg/cm3 relative to L3. mcBMD in all regions decreased over 
time (p<0.02), and change varied by region (time x region interaction p=0.03).The 12 
month decrease in mcBMD was 7 mg/cm3 at L3, 14 mg/cm3 at L4, and 13 mg/cm3 at L5. 
B. DECT mcBMD by treatment (at L4) and time: Mean mcBMD measured by DECT at L4 
did not vary at baseline based on treatment (p=0.42). Chemotherapy decreased mcBMD 
by 23 mg/cm3 (p=0.01) from 0 to 12 months. Radiation decreased mcBMD by 10 mg/cm3 
(p=0.09) from 0 to 12 months, and was lowest at 6 months.  Oophorectomy decreased 
mcBMD by 8 mg/cm3 from 0 to 12 months (p=0.24) and was lowest at 6 months.   
C &D. mcBMD by modalities (at L4) and time:  The median per patient mcBMD percent 
decrease was 14% for DECT, 20% for QCT, and 5% for DXA (p<0.002 for all). The degree 
of decrease was larger in patients treated with chemotherapy or radiation compared to 
oophorectomy, and was statistically significant for QCT (p=0.01), but not DECT (p=0.16) 
or DXA (p=0.29). Note: left subfigure (c) shows absolute measurement and right 
subfigure (d) shows relative change in mcBMD between baseline and 12 months. 
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At baseline, L4 was higher by 12 mg/cm3 and L5 by 25 mg/cm3, relative to L3.  
McBMD decreased in all regions over time (p<0.02), but the degree of change differed 
among the regions (interaction p=0.03). The decrease in mean mcBMD from baseline to 
12 months was 7 mg/cm3 at L3, 14 mg/cm3 at L4, and 13 mg/cm3 at L5. Likewise, 
decreases in mcBMD differed by treatment. Over twelve months, L4 mcBMD decreased 
by 23 mg/cm3 (p=0.01) with chemotherapy, by 10 mg/cm3 with radiation therapy 
(p=0.09) and by 8 mg/cm3 with oophorectomy (p=0.24, Figure 3-6B). Likewise, L5 
mcBMD decreased by 26 mg/cm3 (p=0.01) with chemotherapy, by 13 mg/cm3 with 
radiation therapy (p=0.44) and by 3 mg/cm3 with oophorectomy (p=0.52). One patient 
with a large mcBMD increase confounded the results for the radiation group at L5. 
We next compared changes in L4 mcBMD by treatment and imaging (Figure 3-6C 
and D). Relative decreases were considered for this comparison due to a different 
measurement scale for DXA. The median per patient relative decrease in L4 mcBMD was 
14% by DECT, 20% by QCT, and only 5% by DXA (p<0.002 for all). For QCT, the median 
decrease in L4 mcBMD was 23% with radiation or chemotherapy and 11% with 
oophorectomy (p=0.01).  For DECT, the corresponding reductions were 15% with 
radiation or chemotherapy and 9% with oophorectomy (p=0.16), and for DXA, 6% and 
4% (p=0.29) with the respective cancer treatments.  
Figure 3-7 shows correlations between L4 MF and mcBMD. At baseline, there 
was negative correlation between MF and mcBMD (Figure 3-7A, B). The degree of 
correlation varied depending on imaging modality; correlation was high when MF and 
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mcBMD were measured using DECT and wfMRI, and lower when BMD was measured 
using DXA. Correlations of changes of MF and BMD due to treatment effects were 
substantially reduced or absent (Figure 3-7 C, D).  
 
 
Figure 3-7. Correlation of MF and mcBMD at L4 from different modalities measuring the 
same patient.  The panel on the left shows absolute measurements at baseline.  The 
panel on the right shows changes from baseline to 12 months.  
 
The impact of cancer treatment on circulating adiponectin, resistin, and body fat 
were also measured. The percent body fat measured by DXA for chemo-radiation 
treated and oophorectomy group remained same for the one year study period (p=0.29, 
0.55 respectively, paired t-test). Adiponectin was 7, 10, and 13 ul/ml at 0, 6, and 12 
months respectively and levels increased significantly from 0 to 12 months (p=0.0023, 
repeated measure one way ANOVA).  We observed smaller increases in adiponectin 
after oophorectomy (6, 8 and 9 ul/ml at 0, 6 and 12 months, p=0.16). A weak correlation 
(baseline, r=0.26, 95% CI: (-0.32, +0.69) and change from baseline to 12 months r=0.24, 
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95% CI: (-0.36, +0.70) was observed between MF and adiponectin. Resistin levels 
decreased significantly after radiation and chemotherapy (7, 4 and 3 ng/mL at 0, 6 and 
12 months, p=0.012). By contrast, resistin levels remained stable after oophorectomy (5, 
4 and 4 ng/mL and 0, 6 and 12 months, p=0.63).  
3.4. Discussion 
Cancer survivors’ bone health is an emerging problem, due to continued 
improvements in cancer survival rates worldwide. Appropriate predictive biomarkers 
are needed to identify patients at high risk of bone loss, permitting individualized 
therapy to reduce long-term fracture risk. We observed dramatic increases in MF in 
ovariectomized mice after radiation, without an equivalent loss of either bone or 
hematopoietic cellularity [67]. Since bone surfaces are generally quiescent following 
ovariectomy [73], and rapidly dividing cells are radiosensitive, we expected radiation to 
have greater adverse effects on marrow than bone. We therefore designed the current 
study to investigate changes in MF following treatment with radiation and 
chemotherapy, using oophorectomy as our control.   
Age related osteoporosis is associated with a high inverse correlation between 
MF and mcBMD. In our study, the most striking observation was a failure to maintain a 
high inverse correlation between MF and mcBMD after cancer treatment. Instead, we 
observed rapid expansion of the MF which did not correspond to an equivalent decrease 
in mcBMD. Since MF and mcBMD are not inversely correlated following cancer therapy, 
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our study suggests that BMD and MF should be measured separately. Furthermore, 
DECT and not DXA might be more reliable to measure BMD in cancer survivors, until the 
predictive value of MF is established in predicting fractures. 
To our knowledge, ours is the first study to measure and image MF in ovarian 
and endometrial cancer patients using DECT and wfMRI. Our study confirms that DECT 
can measure changes in both MF and mcBMD after cancer treatment. MF increased 
significantly more following radiation and chemotherapy, relative to oophorectomy 
(interaction p<0.001). We therefore conclude that increased MF in cancer patients is not 
due to loss of ovarian function alone. Kugel et al. measured vertebral MF using magnetic 
resonance spectroscopy; MF increased by <1% per year between ages 30-60 in women 
[74]. By contrast, cancer survivors in our study experienced large (9-32%) increases in 
MF over one year. Interestingly, regions demonstrated heterogeneity in MF at baseline. 
Additionally, changes in MF varied by both treatment and time, possibly due to differing 
treatment schedules for chemotherapy (several months) versus radiation (one month). 
In the case of radiation, the 6 to 12 month increase in MF was relatively smaller than the 
0 to 6 month increase. Whether this adipogenic process continuously increases with 
time, or stabilizes, is of our future interest. Study participants experienced increases in 
serum adiponectin that were not associated with increased body fat, but were 
associated with increased MF. Cawthorn et al. (personal correspondence) found that MF 
could generate adiponectin. Future studies are needed to clarify whether serum 
adiponectin levels can be used to judge changes in MF associated with cancer therapies.  
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Our study had several limitations. The sample size was relatively small and the 
study period was limited to one year. Subgroup analysis was limited, as numbers in each 
treatment group were small. Since the field of view of second energy source was smaller 
than the first in DECT scanner (30 cm vs. 50 cm, respectively), one may need to be 
careful while deriving parameters such as MF and mcBMD. The measured MRI fat 
fraction used in this study included some bias from T1 and T2*, which could be 
corrected in future work with more sophisticated acquisition and reconstruction 
techniques [75]. Finally, the small number of serum samples (n=14) limited our ability to 
assess changes in serum adiponectin and resistin by treatment group.   
3.4.1. Conclusions 
In summary, we established the feasibility of DECT and WF-MRI to measure the 
impact of cancer treatment on MF and mcBMD. Because CT is routinely used to 
diagnose cancer and monitor response to therapy, DECT could characterize changes in 
skeletal health (MF and mcBMD) with little or no additional cost or radiation exposure. 
We suggest that MF and mcBMD should be considered independently, when monitoring 
the adverse effects of cancer therapy. Future longitudinal studies in cancer survivors are 
needed, to determine how long increased MF persists following cancer therapy, how 
changes in MF associate with changes in mcBMD, whether serum adiponectin can be 
used to measure changes in MF, and how MF changes correspond to risk of incident 
fracture.   
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CHAPTER 4:  VALIDATION OF MARROW FAT ASSESSMENT 
USING NONINVASIVE IMAGING WITH HISTOLOGIC 
EXAMINATION OF HUMAN BONE SAMPLES 
4.1. Introduction 
Cancellous bone of a single vertebral body is heterogeneous and the density of 
which can vary by as much as 20% [76].  Common in vivo methods of assessing 
cancellous BMD (e.g. DXA, Quantitative Computed Tomography) integrate the density of 
calcified tissue with marrow density.  However, marrow composition can vary from 
higher density hematopoietic red marrow to lower density adipocytic yellow marrow.  
Increased marrow fat can also alter microstructure heterogeneity of the trabecular 
matrix and has also been shown to influence vertebral failure patterns [77-79].  Most 
bone histopathology studies were limited in focus to studying osseous structures [80-
82] or specific pathologic abnormalities in cancellous bone [83-85]. To our knowledge, 
there has been no study performed to correlate in vivo imaging of bone and bone 
marrow with coregistered histologic quantification of marrow fat. 
We present here a study on the correlation between histologic examination of 
marrow fat fraction and clinical imaging by means of Dual Energy Computed 
Tomography (DECT) and Magnetic Resonance Imaging (MRI). DECT has the ability to 
identify marrow composition through use of basis material decomposition techniques 
[17].  We have already developed water-fat MRI in a previous study to measure the fat 
fraction signal in bone marrow [86].   
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4.2. Method and Materials 
4.2.1. Subjects 
Donors were accepted into this study as part of a larger investigation into the 
heterogeneity of cancellous bone.  Approval was given by the Anatomy Bequest 
Program at the University of Minnesota. The five donors were female with a mean age 
of 57.5 ± 9.3 years.  Each subject was diagnosed with cancer and last treated with 
radiation or chemotherapy within the past 6 months.  The diagnoses included cancer of 
the cervix, breast, and epiglottis and Chronic Lymphocytic Leukemia.  Potential subjects 
were excluded with a history of knee, hip, or shoulder replacement, obesity, or history 
of treatment for osteoporosis (i.e. a Bisphosphonate).  Donors were received by the 
University of Minnesota Anatomy Bequest Program.   
4.2.2. Imaging 
Within 24 hours postmortem, fully intact bodies were brought to the Radiology 
department at the University of Minnesota Medical Center, Fairview in Minneapolis, 
MN.  Each body was first imaged using a Siemens Somatom Definition Flash DECT 
scanner (Siemens Medical Solutions USA, Inc., Malvern, PA, USA).  The scan utilized Dual 
source CT at energies of 80kVp and at 140kVp with an additional tin filter for accurate 
image co-registration.  Each donor was scanned cephalic caudal to include the entire 
skeleton.  17 vertebral bodies were analyzed with both MRI and DECT and then 
processed for H&E examination.   
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For DECT, yellow marrow volume fractions (YMF) were calculated from basis 
material composition estimates for bone ROIs relative to manufacturer-reported basis 
material compositions for the CT calibration phantom (Figure 4-1E and F). The basis 
material composition formulas used were the same as used in Section 3.2.2.  Since red 
bone marrow is more dense than water, values of P can range from -66% to 100%. The 
CT-derived estimate of MF was then normalized to the MRI scale without affecting 
correlation using: YMF = 0.6 * (P + 0.396).   
After DECT imaging, the donor was brought to the MRI and imaged on a Siemens 
Magnetom 3 Tesla MRI scanner (Tim TRIO, Siemens Medical Solutions, Malvern, PA, 
USA).  Three water-fat source images were created with TE = 2, 3, and 4 ms.  Specific 
parameters can be found in Bolan et al. [86].  Water-fat reconstructions were produced 
from the three multichannel datasets using the method of Berglund et al. [87] (Figure 
4-1C and D).  Signal-fat fraction (sFF) images were produced and ROIs were recorded in 
order to ensure accurate co-registration with DECT imaging.   
4.2.3. Excision, registration technique 
After clinical imaging, vertebral samples were removed by the University of 
Minnesota Bequest program staff.  Vertebral bodies were separated from the pedicles 
using a diamond tipped bone saw and placed in formalin.  21 individual Lumbar 
vertebrae were then cleaned of soft tissue to expose cortical bone.   
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Figure 4-1.  Multi-Modality Co-registration between histologic examination and in vivo 
imaging.  Two vertebral bodies analyzed: top row is representative case of lower 
marrow fat and bottom row is higher marrow fat.  A. & B. axial section of whole 
vertebral body with H&E staining.  Void spaces of adipocytes were contoured by 
threshold and artifacts were removed at the discretion of the investigator.  C. & D. 
water-fat MRI images of lumbar vertebrae and example of ROI placement.  E. & F. DECT 
images reconstructed to highlight marrow fat intensities.  For imaging modalities, red 
represents high marrow fat concentration. 
 
The vertebral bodies were cut with a DELTA PEC bench band saw (Chang Type, 
Taiwan) to remove superior and inferior aspects and keep a 5mm section.  Taking a 
histologic section from the center of the vertebral body ensured that the AV/TV was 
taken from a representative section of the imaging ROI.  These sections were decalcified 
(Formical-2000, Decal Chemical Corp., New York, USA) (20x volume per sample) until the 
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cortical bone was completely demineralized.  The sections were cut mid-sagittally to 
make left and right halves.  Each vertebral half was then embedded in paraffin wax and 
stained by the H&E staining method. Eight vertebral bodies midsections were processed 
whole instead of being cut in half so that matching ROIs could be analyzed (Figure 4-1A 
& B). 
4.2.4. Histology image tile procedure 
A full digital image of each vertebrae half was produced by image tiling with a 
Nikon AZ100M Macro Fluorescence Scope (Nikon Corporation, Tokyo, Japan) with a 
color camera at 4x magnification. The cellular components of the produced images were 
then analyzed using ImageJ [49]. The scale was calibrated to 512 pixels/mm and the 
images were converted to an 8-bit gray scale. An approximately 2 mm diameter region 
of interest in each vertebra half was selected and areas of high artifact were avoided. A 
threshold was applied to identify adipocytes as void spaces remaining from the H&E 
staining process.  Non-adipocytic void spaces, commonly seen as artifacts in H&E 
staining, were excluded from this selection process at the discretion of each user.   
Adipocyte volume per tissue volume (AV/TV) was calculated for each half. The AV/TVs 
for both halves were averaged together.    
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In order to test variability, histologic examinations were also performed at 0.5 
cm superior and 0.5 cm inferior to the middle in three vertebral bodies.  Also, two 
investigators examined the histology images for the marrow fat ratio in order to test 
inter-user variability.   
4.3. Results 
DECT-derived yellow marrow fraction estimations were calculated for all 25 
lumbar vertebrae in the five donors.  YMF ranged from 0.07 to 0.91 for the lowest and 
highest fat signal, respectively.  For wfMRI-derived signal fat fraction, values could only 
be determined for 20 lumbar vertebrae; one subjects had poor signal to noise ratio 
above L5 and another had a poor signal to analyze L1.  Values ranged from 0.22 for less 
fatty marrow to 0.79 for the highest sFF.   
The AV/TV of 21 lumbar vertebrae ranged from 0.18 to 0.75 with a mean (SD) of 
0.36 (0.18).  Vertebral bodies take from the same cadaver showed much less diversity as 
seen by standard deviations of AV/TV between 0.03 and 0.07.  For the three vertebrae 
that were analyzed at three levels within 1 cm, the average coefficient of variation 
between the sections was 0.08.  There was a high correlation between the two users, r = 
0.99.    
17 vertebral bodies were scanned with both DECT and wfMRI and then 
processed for H&E examination.  There were moderate correlations between the AV/TV 
and the results of DECT and wfMRI (r = 0.80 and 0.77, respectively) (Figure 4-2A).  A 
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higher correlation was seen between the two imaging modalities with similar ROIs than 
with histology (r = 0.88) (Figure 4-2B). 
4.4. Discussion 
Current clinical practice of marrow fat assessment typically involves an invasive 
and painful bone marrow biopsy of the posterior iliac crest.  However, this method does 
not give an accurate picture of the heterogeneity that is present in bone marrow 
throughout the body.  For the first time, AV/TV quantifications taken from vertebral 
bodies have been correlated with results from dual energy CT (DECT) and wfMRI 
modalities.  Both DECT and wfMRI were able to estimate yellow marrow fat fractions as 
validated by AV/TV in 17 coregistered samples.   
Although bone marrow adipocyte parameters have been used to quantify 
marrow fat from trephine biopsies of the iliac crest [88-91], it is not commonly used on 
H&E stains of intact vertebral body cross-sections.  In our small sample size, we found 
that inter-subject AV/TV can vary by nearly 60%, and even different intra-subject sites 
varied by as much as 40%.  This high variability could be due to the diverse treatment 
effects each individual received prior to death or just a reflection of the true 
heterogeneous makeup of bone marrow within individuals. The technique used to 
estimate AV/TV is highly reproducible if proper instruction is given for estimating 
adipocyte grayscale threshold.   
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Figure 4-2.  Marrow fat estimation from histology and in vivo imaging modalities.  A) 17 
vertebral bodies were imaged with DECT and MRI and then processed for H&E 
examination.  Results of the imaging are compared with histologic adipocyte volume per 
tissue volume. B) Correlation between the marrow fat estimation results from two non-
invasive imaging techniques. 
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4.4.1. Clinical implications 
With the increased commercial availability of dual energy CT scanners and recent 
proof of acceptable dose exposure [69], DECT is becoming more prevalent in hospitals 
and treatment centers.  The ability to measure marrow fat at any cancellous bone site 
could provide a pathway for studies to monitor changes, in vivo, using DECT.  It may also 
be useful in radiation therapy treatment planning where targeting of active bone 
marrow would reduce the radiation treatment exposure to healthy tissue.  DECT can 
easily be adapted in the treatment facilities (e.g. radiation oncology departments) 
where whole body PET/CTs are commonplace and single energy CT imaging is commonly 
performed to monitor cancer survivors.   
4.4.2. Limitations 
The subjects in this study were all given cytotoxic treatments within the last 6 
months before death which is known to affect the bone marrow composition.  
Investigations into the true variation in the average human body would need this 
examination repeated with a more controlled population.  However, this study was 
focused on validating marrow fat fraction estimation from in vivo imaging techniques.  
Decomposition processes may introduce some bias into the data.  However, these 
processes are likely to be negligible, as bone marrow from recently deceased individuals 
is commonly transplanted to immunocompromised patients.  
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4.4.3. Conclusion  
In conclusion, cancellous bone regions were examined by histology and co-
registered in vivo clinical imaging.  Marrow fat fraction intensities taken from imaging 
were validated with histologic quantification of adipocyte prevalence.   This may be able 
to monitor bone health of individuals who have undergone cytotoxic treatment, 
especially the cancer survivor.   
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CHAPTER 5:  IN SITU ASSESSMENT REVEALS SKELETAL-WIDE 
HETEROGENEITY OF HUMAN CANCELLOUS BONE 
5.1. Introduction  
Although skeletal health is most often clinically assessed by measuring the bone 
mineral density (BMD) of the lumbar spine and proximal femur, this common clinical 
practice assumes homogeneity between these sites and the entire skeleton.  Our 
previous work in a mouse model has demonstrated that the skeleton is heterogeneous 
and has an immediate response from treatments such as radiation and chemotherapy 
[92].  However, no studies have been performed to assess the skeletal-wide BMD 
variation in humans. Several studies have shown that the majority of fractures occur 
outside of the axial skeleton [93-95].  According to Amin et al., fractures in the spine and 
proximal femur comprise only 30% of fragility fractures [96].  Therefore, a method of 
imaging the entire skeletal system might improve the ability to identify and treat 
patients at high risk of fractures.  
 Recently, cancellous trabecular microarchitecture within a single vertebral 
body was found to be heterogeneous at different sections [77].  If cancellous bone is 
inhomogeneous within an individual vertebrae, then heterogeneity of cancellous bone 
along the entire skeleton could also exist.  Current methods of assessing bone health 
(i.e. Dual-energy X-ray absorptiometry, DXA) superimpose cortical and cancellous bone, 
thereby masking true cancellous bone characteristics.   
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For this study, we separate the term ‘cancellous’ bone into two regions, a 
calcified trabecular matrix and a marrow space containing a ratio of red to yellow bone 
marrow.  Similar to the ratio of cancellous to cortical bone, the ratio of red to yellow 
bone marrow also varies from site to site [97].  As mentioned in Section 1.3, accurate 
BMD assessment can be problematic when using traditional methods (i.e. DXA or 
Quantitative Computed Tomography (QCT)) which do not correct for marrow 
composition [21, 98, 99]. Recent improvements in CT scanners, including dual energy, 
large bore, and larger couch travel, have provided accurate and efficient in 
investigations of the whole body, including quantification of marrow fat [100].   
The primary goal of this study was to quantitatively image the entire skeleton in 
order to characterize the heterogeneity of cancellous bone.  The secondary goal was to 
evaluate whether marrow-corrected BMD (mcBMD) (derived using DECT) had similar 
characteristics to uncorrected BMD (derived using QCT). Finally, we investigated 
potential differences in skeletal heterogeneity between subjects with and without a 
history of cancer treatment (i.e. chemotherapy).   
5.2. Methods 
5.2.1. Subjects 
Over a 10 month period, twenty recently deceased human donors were 
accepted in the imaging study.   All donors or their next of kin/authorizing person 
consented to donate her bodies to aid in anatomy education and research in accordance 
with the Minnesota Darlene Luther Revised Uniform Anatomical Gift Act.  Donors were 
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all Caucasian women between the ages of 40 and 80 years old, less than 190 cm tall, and 
were imaged within 24 hours postmortem.  The height restriction ensured that the body 
could fit within the longitudinal length of the CT scanner.  In order to normalize mcBMD 
values from the 20 subjects, an age correction factor was taken from a recent 
investigation on the effects of age on cancellous volumetric BMD [101].  Since 
cancellous bone changes much more drastically with age than combined cortical and 
cancellous, a correction based on DXA values would not be accurate and, in fact, were 
less drastic than volumetric BMD correction (data not shown).  The average applied age 
correction was approximately 10% with a standard deviation of 27%.   
Two groups of donors were assessed in this study; those treated with 
chemotherapy (n=10) or controls (n=10) without bone afflicting conditions (e.g. not 
treated for cancer, hyperthyroidism, or Paget’s disease).  Donors with history of cancer 
treatment were included only if their last round of chemotherapy was less than a year 
before death. 
5.2.2. Imaging 
Within 24 hours of death, bodies were taken to the radiology department at the 
University of Minnesota Medical Center – Fairview for whole body dual energy CT 
scanning. Although the term ”in situ imaging” is accurate for the assessment of 
cadavers, dual energy computed tomography (DECT) imaging can be used in vivo. 
Imaging was obtained using a Siemens® SOMATOM Definition Flash Dual Energy CT scan 
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(Siemens Healthcare, Forchheim, Germany) at energies of 80kVp, 500mm SFOV, and 
306-308mAs for Source A, and 140kVp, 328mm SFOV and 110-150mAs with a tin filter 
for Source B.  During imaging, subjects were placed in a supine position with arms to the 
side.  The SOMATOM DECT unit was calibrated for both energies using the Mindways 
Software, Inc. (Mindways Software, Austin, TX, USA) QCTPro calibration Phantom.  The 
table height was varied to ensure that the patient was in the center of the imaging field, 
regardless of body size.  A calibration was performed for each table height. 
5.2.3. ROI analysis 
Using software developed by Mindways Software, Inc. (Austin, Texas, USA) and 
anatomical landmarks, regions of interest (ROIs) were placed in the same location on 
the 80kVp and Sn140kVp CT scans.  Twenty-three cancellous bone locations were 
analyzed (Figure 5-1) which included: the skull, twelve sites from the spine, two from 
the arm, three from the hip, two from the knee, and three from the ankle/ foot.   
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Figure 5-1. 23 Regions of Interest representing areas of analyzed cancellous bone with 
representative case for ROI Placement of L3 
The size of each ROI depended on the bone being measured but ranged from a 
cylinder of 20mm2 x 3mm for the posterior occipital diploë (“skull”) to 300mm2 x 9mm 
for the lumbar spine.  Care was taken to exclude any area where a fracture had 
occurred, especially in a vertebral body.  Similarly sized ROIs were placed at each 
skeletal site for all donors.  Vertebrae were analyzed at the center of the vertebral body 
in the superior-inferior axis.   
5.2.4. Basis Material Composition  
A commercially available CT calibration phantom (Mindways Software, Inc. 
Austin, TX) was used in each imaging procedure.  This phantom was composed of 
different rods of known water and K2HPO4 concentrations.  When scanned with two 
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different energies in the diagnostic range, the x-ray attenuation of biologic tissue can be 
described by the linear combination of the x-ray attenuation properties of these two 
materials [17, 102].  Using the publically available XCOM database to estimate energy-
dependent, mass attenuation coefficients, the average atomic composition for basis 
materials can be estimated [103].  The International Commission on Radiation Units and 
Measures has documented average atomic compositions of adipose tissue, yellow 
marrow, and red marrow (0.91 g/cm3, 0.93 g/cm3, and 1.03g/cm3, respectively (ICRU 
publication 46))[104].  When combined with XCOM, these values were used to derive 
the basis material compositions in our ROIs.  Bone mineral density values can then be 
corrected for marrow composition at each skeletal site.   Further details of basis 
material decomposition are part of another submitted manuscript. 
5.2.5. Statistics  
Mean QCT-derived BMD and mcBMD values were determined at each skeletal 
site for both control donors and donors treated for cancer.  Significant differences in 
QCT-derived BMD and mcBMD were assessed by a paired t-test for each skeletal site.  
The mcBMD results for each skeletal site were correlated to every other site, by control 
or cancer group, using the Pearson Product-Moment Correlation Coefficient.  To 
measure the significance of differences seen between mean mcBMD values of cancer 
and control donors, two sample t-tests and F-tests were performed at every skeletal 
site.  
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5.3. Results 
The average age for all subjects was 62 years (range, 40-80 years). The mean (SD) 
height and weight for subjects was 165 cm (7 cm) and 63kg (20 kg), respectively 
resulting in a BMI of 23.0 (6.4 kg/m2). Causes of death included cancer (n=11 (one 
cadaver was never treated)), Parkinson Disease (n=2), chronic obstructive pulmonary 
disease (n=2), hepatitis (n=2), sudden cerebrovascular accident (n=2), and heart failure 
(n=1).  Location and extent of disease in the cancer-treated group included: Breast 
cancer (n = 3), Ovarian/endometrial cancer (n = 3), urinary tract cancer (n = 2), tumor of 
the epiglottis (n = 1), and recurrent Chronic Lymphocytic Leukemia (n = 1) malignancies.  
One subject, from the cancer-treated group, sustained a proximal femur fracture 
approximately one month before death but was never treated, while another donor, 
from the control group, had prior bilateral knee replacement and shoulder 
reconstructive surgery.  The high density material and resulting streak artifact made 
assessment of those regions unattainable in those two subjects. 
 For the 23 skeletal sites, the average BMD using 140kVp QCT corrected for 
age was 145 mg/cm3, and ranged from 835 mg/cm3 for the skull to -52 mg/cm3 for the 
proximal humerus. Differences between BMD values for 80kVp and 140kVp correlated 
well (r = 0.91).  Figure 5-2 compares BMD results from the 140kVp QCT dataset to the 
marrow-corrected DECT dataset.   
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Figure 5-2. Cancellous Bone Mineral Density distribution for 23 skeletal sites (skull 
separately). 
 
 
Notice at most vertebral sites, the BMD values are higher when marrow is left 
uncorrected (as assessed by QCT) than when corrected (as assessed by DECT) and vice 
versa for sites more caudal (e.g. tibia).  At 14 of the 23 skeletal sites, the average 
difference between QCT-derived BMD and mcBMD was significant at the 0.10 level with 
a similar numbered amount of sites (12) having a Pearson correlation of r > 0.7.  McBMD 
at each skeletal site also correlated well (average pairwise correlation r > 0.6) with other 
sites except for the femoral neck and proximal humerus (Figure 5-3).   
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Figure 5-3. Average correlation between representative skeletal sites for marrow-
corrected BMD. 
 
These two sites were also the least dense with a mean mcBMD of 35 mg/cm3 
and 2 mg/cm3, respectively.  Excluding the skull, the average (SD) mcBMD derived by 
DECT was 114 mg/cm3 (67 mg/cm3) with the densest site being the talus (244mg/cm3).  
We also observed a gradual decline in mean mcBMD in the axial skeleton from the top 
of the spinal column to the bottom (236 mg/cm3 for C3; 96 mg/cm3 for L5).    Local 
differences in mcBMD were also seen within individual bones such as the femur and 
tibia.  Cancellous mcBMD was lower in the proximal femur than the distal femur (39 
mg/cm3 and 66mg/cm3, respectively), and significantly lower (p < 0.001) in the proximal 
tibia than distal tibia (54 mg/cm3 and 174mg/cm3, respectively).    
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Separating the marrow- and age-corrected results of the cancer and control 
groups showed intra-site mcBMD similarities.  Statistical tests of differences of the mean 
or variance between cancer and control donors showed no mcBMD differences at most 
regions.  The only exceptions were C7 and the ilium, which had a larger variance in the 
control group (p = 0.039 and 0.031, respectively), mostly due to a high mcBMD value in 
a control donor.  All other tests had p > 0.1, suggesting that, on average, the cancer and 
control groups had similar mcBMD.  However, a higher average pairwise correlation 
between other skeletal sites was seen in the controls (r = 0.61 and 0.33, respectively) 
(Figure 5-4).   
 
Figure 5-4. Mean correlation in mcBMD between 23 skeletal sites.  Correlation 
coefficient was calculated for the mcBMD of each individual site vs the 22 other sites.  
Averages for control subjects vs cancer subjects are compared. 
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This shows that while control and cancer groups had similar mcBMD on average, 
the control group exhibited more consistent relationships among sites within individual 
patients.  We noted that skeletal sites adjacent to each other had higher correlation in 
mcBMD than skeletal sites distant to one another (e.g. C3-C7 versus C3-distal tibia, 
respectively). More details can be found in the supplemental data.   
5.4. Discussion 
One of the most critical misconceptions in bone health today is the assumption 
that the entire skeletal system can be represented within a single biopsy or the 
uncorrected BMD measurements of a few sites.  However, previous studies have found 
more than 70% of fractures occurred at locations other than the lumbar spine and hip 
[96, 105].  Our study documents common heterogeneity of cancellous bone throughout 
the skeleton, with higher bone mineral density in the cranial and caudal sections and 
lower density at the midline (i.e. hip and pelvis).   Even individual bones had differences 
in mcBMD, such as seen between the proximal and distal ends of the tibia and femur.  
We compared our data to the fracture incidence location by Amin et al.  We found a 
small inverse correlation between average mcBMD values for each skeletal site and 
fracture incidence location (r = -0.25).  This is the first reported comparison of skeletal-
wide bone mineral density heterogeneity with fraction incidence locations.  Although 
not a high correlation, other factors, such as cortical bone integrity and structure, may 
also influence facture incidence. 
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The correlation between QCT-derived BMD and mcBMD was high even though 
there were significant differences between the two.  The pattern of heterogeneity 
between the axial skeleton and bones of the limbs was apparent in both modalities.  A 
decreased average correlation between skeletal sites suggests a disruption in mcBMD 
heterogeneity due to a systemic effect of cancer treatment.  Correcting for marrow 
composition can provide a more accurate estimate of the osseous density within a 
bone.   
There are several explanations regarding the cause of cancellous bone 
heterogeneity.  As well as structural support for mechanical motion, the skeleton is also 
an optimal site for calcium and mineral storage.  The trabecular matrix can rapidly store 
and reabsorb minerals due to a high surface area.  However, as humans age the need 
for rapidly accessible minerals decreases while the need for structural support remains.  
Perhaps this explains why the young have a higher ratio of vertically to horizontally 
oriented trabeculae than older individuals [106].  In addition to mechanical stress, the 
epigenetic postcode can also affect the rate of remodeling at different cancellous sites 
throughout the skeleton.  We suggest that heterogeneity of mcBMD in the skeleton is 
due to combination of each skeletal site’s mechanical stress and bone cell lineage along 
with the person’s age.   
To our knowledge, this is the first study to image the entire skeleton in vivo and 
correct for marrow composition using advanced computed tomography.  Higher 
correlation of more adjacent vertebral sites is a finding similar to a 2011 study which 
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imaged the thoracic and lumbar spine in over 1,000 subjects [78].  This supports the 
theory that skeletal sites retain a genetic postcode that unique affects different regions 
of the body.  Previous investigations attempted to quantify skeletal heterogeneity for a 
few specific skeletal sites in terms of bone ash weight [107], histologic examination 
[108], or micro-CT [80].  However, none of these investigations presented an in vivo 
technique for assessment of cancellous bone heterogeneity.   
Chemotherapy is reported to adversely affect bone and bone marrow in clinical 
studies [109-111].  Less correlation between control and cancer-treated groups may be 
due to unequal damage to different skeletal regions due to cytotoxic treatment (e.g. 
chemotherapy and radiation).  Structural properties as well as marrow content vary 
across the skeletal system and may therefore have different skeletal effects from cancer 
treatment.    
Monitoring changes to the heterogeneity of cancellous bone might identify sites 
with a higher rate of bone turnover that are more prone to fracture.  It may provide the 
ability to create a predictive model to estimate what the average value of a certain bone 
should be, compared to the rest of the skeleton.  Deviations from the predictive model 
in individual patients could highlight areas where local disease might be present.  It 
might also be used to monitor changes in skeletal health resulting from chemotherapy, 
radiation therapy or disease progression. Although CT imaging increases radiation 
exposure to patients, whole body CT scans are already performed as part of a positron 
emission tomography (PET)/CT and during some radiation therapy treatments. To date, 
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such images are taken with single energy CT and only used for anatomical referencing.  
However, we expect PET studies to soon take advantage of reduced radiation exposure 
from DECT scans [112-114] and be able to monitor bone health.   
5.4.1. Limitations 
The present study was a feasibility study and did not have a high sample size.  
We limited participants to donors who had pre-arranged anatomical donation contracts 
with the University of Minnesota Bequest Program.  This happened to result with only 
Caucasian women being enrolled in the study. Also, the age correction used in this study 
was taken from a QCT publication examining the effect of age on the thoracic and 
lumbar vertebrae and did not correct for marrow composition or provide different 
corrections for all skeletal sites.  Similar errors would be apparent in DXA, but even 
more so since this modality does not separate the thick exterior cortical bone from the 
interior cancellous bone.  For the cancer-treated patients, there were uncertainties in 
treatment regimen because of patient grade, response, etc. as it was not a controlled 
study.  However, the goal of this publication was to be a feasibility study.   
5.4.2. Bone Mineral Density Heterogeneity Index Model 
A value, termed Heterogeneity Index number, can be calculated by normalizing 
the function of average mcBMD for each skeletal site to a single site (e.g. T2).  Thus, any 
site could be used in a linear calculation to estimate the mcBMD of any other site.  For 
this study, T2 was used to test accuracy of the SEDD model.  Measured mcBMD values 
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of cancer subjects at every site excluding the skull were compared to their estimated 
mcBMD values calculated from only the T2 value. 
 
Figure 5-5.  The heterogeneity index is presented for each of 22 skeletal sites (excluding 
the skull). Results are the average marrow corrected bone mineral density values from 
ten control subjects. Interestingly, heterogeneity was similar in adjacent bones. 
Additionally, there was greater heterogeneity in the superior versus inferior (cervical 
versus lumbar) spine. Heterogeneity was also higher toward the skull and feet, and 
lower in the mid-body.   
 
The Heterogeneity Index normalized to T2 is shown in Figure 5-5.  An empirical 
model was created which utilized the Heterogeneity Index to estimate the skeletal-wide 
bone mineral density distribution (SEDD) from just one measured site (Figure 5-6a).  
Results of skeletal mcBMD estimation from the 2nd Thoracic vertebrae of cancer donors 
using the SEDD model are compared to their measured values in Figure 5-6b.  The 
average measured and estimated mcBMD values were correlated very well, r=0.95.  T6 
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and L1 were the only estimated skeletal sites that were not significantly different (p > 
0.1) from measured values and largely due to a single donor.  
Bergmann et al. showed a variation in the rapidly exchangeable calcium pool 
between different skeletal regions.  We did find a moderate correlation between their 
results and our heterogeneity index (r = 0.65).  This indicates the model of bone 
remodeling may have similarities with cancellous mcBMD as measured by DECT.  
However, their method was limited by the technology of the day and could not separate 
cancellous bone from cortical, much less individual bones.   
The SEDD model has the potential to be a clinically relevant prognostic tool.  
Monitoring changes to the heterogeneity of cancellous bone might identify sites with a 
higher rate of bone turnover that are more prone to fracture.  It may provide the ability 
to estimate what the average value of a certain bone should be compared to the rest of 
the skeleton.  The SEDD model could highlight areas where local disease might be 
present.  It might also be used to monitor changes in skeletal health resulting from 
chemotherapy, radiation therapy or disease progression. Although CT imaging does 
increase radiation dose to patients, whole body CT scans are already performed as part 
of a positron emission tomography (PET)/CT and during some radiation therapy 
treatments.  To date, such images are only used for anatomical referencing and not for 
monitoring bone health.   
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Figure 5-6.  Prediction of marrow-corrected cancellous Bone Mineral Density (mcBMD) 
values from a single measured value.  A) Application of the skeletal-wide estimated 
density distribution (SEDD) model.  Using the relationship between the average 
cancellous mcBMDs from all clinical sites of control subjects, a model was developed to 
estimate mcBMD for the entire skeleton from just one site.  All values were corrected 
for age and marrow composition.  If given a measured (known mcBMD) value of any test 
site (Known location), mcBMD values of 22 skeletal sites can be estimated.  B) 10 
cancer-treated donors were imaged with whole-body DECT using the SEDD model. The 
measured mcBMD value of the L1 from 10 cancer treated donors was used to estimate 
the 21 other skeletal sites.  Mean predicted (95% confidence level) and measured values 
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(SD) are shown.  Only the T2 and L1 had significant differences between measured and 
estimated mcBMD (p < 0.1, t-test).  A high correlation was seen between the average 
predicted and measured values for the donors (r = 0.95).   
 
Although Samelson et al. only imaged the lower thoracic and lumbar vertebrae, 
we found their observed difference between the trabecular BMD of the T-spine and L-
spine was within 3% to our SEDD model (94% vs 91%, respectively) [101]. However, their 
study did not correct for marrow composition.  We further wanted to test our model 
using images from a DECT feasibility study.  The abdomen and pelvis of 27 subjects 
enrolled in a clinical trial were imaged using DECT [115].   L5 and femoral neck mcBMD 
values were predicted from measured L3 values (Figure 5-6).  The average predicted 
mcBMD was accurate to within 7% and 19% of the measured value for L5 and the 
femoral neck, respectively. A better correlation was seen between measured and 
predicted L5 than femoral neck (0.50 and 0.12, respectively).   
5.4.3. Conclusion 
Bone mineral density varies among cancellous bone sites along the entire 
skeleton.  With the ability to correct for marrow composition, DECT imaging of the 
entire human body can accurately assess cancellous mcBMD heterogeneity.  The trend 
of cancellous BMD among skeletal sites was similar for QCT and DECT.  However, 
marrow correction did reveal dynamic differences in some skeletal sites.  No significant 
differences were seen between mean mcBMD values for control donors and those 
treated for cancer, although correlation between skeletal sites was weaker in the cancer 
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group.  These findings suggest potential for developing a skeletal heterogeneity model 
in further prospective studies, which could predict individual mcBMD values based on 
sites elsewhere in the skeleton, and identify abnormalities in patients who deviate from 
the model. 
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CHAPTER 6:  CONCLUSION 
6.1. Summary and general conclusions 
Skeletal health is becoming a critical subject with the aging and cancer survivor 
population.  Fractures cause a large economic burden and their effect can range from 
restricted lifestyle to death.  An important area of research involves developing new 
biomarkers in order to assess the health of bones.  Methods of assessing bone health in 
vivo have the potential to monitor changes at critical locations without the need for 
invasive biopsies or large mouse populations.   
In this work, several modern modalities were explored and utilized in order to 
investigate the relationship between bone marrow, BMD, and their heterogeneity 
throughout the whole mammalian body.   A major strength of in vivo imaging in pre-
clinical and clinical trials is highlighted in the ability to repeatedly measure the same site 
for treatment effects in the body.  To that aim, it is necessary to characterize each 
modality in terms of imaging parameters and operating costs.  The modalities in this 
document are relatively new techniques.  Therefore, there is not much literature 
regarding parameters for pre-clinical in vivo imaging or utilizing DECT for longitudinal 
studies.  Therefore, the work presented here aims to provide information on the effect 
of bone afflicting disorders both locally and systemically.   
When working with the murine model, it is possible to measure simulated 
treatment conditions and monitor changes that would be experienced by a patient 
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undergoing cancer treatment.  Optimized micro-CT parameters provide quality images 
that are sufficient for examining longitudinal changes in the trabecular bone of mice.   
Micro-CT can also be useful in monitoring both local and distal skeletal sites in 
response to radiation injury [116]. This technique may permit investigations into the 
multi factorial communication pathways between the two active tissue components in 
skeletal metabolism.  After dual isotope analysis, there appears to be some functional 
skeletal heterogeneity among marrow and calcified tissues. Exposure to localized 
radiation causes different longitudinal changes in marrow metabolism and mineral 
remodeling both in the exposed area and in the abscopal skeleton.   
Technological advancements in dual energy CT have made it a modality capable 
of simultaneously quantifying the two compartments of cancellous bone (i.e. the 
calcified trabecular matrix and the marrow compartment).  However, in order to prove 
marrow composition, it is necessary to confirm DECT with co-registered histologic 
examination of cancellous bone.  We have provided marrow fat fraction intensities 
taken from both DECT and commonly accepted water-fat MRI.  Results from both 
modalities had a strong relationship with histologic quantification of adipocyte 
prevalence (r > 0.75).   DECT has the ability to monitor the proliferation marrow fat 
without the need for invasive biopsies or an expensive wfMRIs. 
Utilization of DECT and wfMRI in our clinical trial confirms that DECT can 
measure changes in both MF and mcBMD after cancer treatment. We found that MF 
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increased significantly more following radiation and chemotherapy, relative to 
treatment with an oophorectomy alone. Therefore, it can be concluded that loss of 
ovarian function alone cannot explain the increased MF in cancer patients. We also 
challenge current dogma and showed that the cancer survivors in our study experienced 
large increases (9-32%) in MF over one year.  
Another dogma being challenged with this work is the assumption that the 
entire skeletal system can be represented within a single biopsy or the BMD 
measurements of a few sites.  We have shown that cancellous bone is heterogeneous 
throughout the skeleton with assessment of the whole body using DECT imaging.  A 
higher bone mineral density was seen in the cranial and caudal sections and lower 
density at the midline (i.e. hip and pelvis).   Even individual bones had differences in 
marrow-corrected BMD, such as seen between the proximal and distal ends of the tibia 
and femur.  We compared our data to the fracture incidence location and found a small 
inverse correlation between average marrow-corrected BMD values for each skeletal 
site and fracture incidence location (r = -0.25).  This is the first reported comparison of 
skeletal-wide bone mineral density heterogeneity with fraction incidence locations.   
6.2. Potential applications 
6.2.1. Murine Study 
The use of micro-CT/PET may be useful for monitoring local and distal skeletal 
sites in response to radiation injury. Using each mouse as its own control would 
significantly decrease the need for an inordinate number of mice.  Combined with the 
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ability to image multiple mice in each scan, micro-CT/PET can be reasonably priced and 
still provide detailed information on both local injury to bone as well as the abscopal 
response from distant skeletal sites.  Our initial work did find some functional skeletal 
heterogeneity among marrow and bone tissues. Molecular and biochemical 
mechanisms could still be further investigated.   
6.2.2. Human Study 
In our studies, we suggest that MF and mcBMD should be considered 
independently, which DXA and single energy quantitative computed tomography cannot 
do.  Separating MF and mcBMD should be done especially when monitoring the adverse 
effects of cancer therapy. Future longitudinal studies in cancer survivors are needed in 
order to 1) determine how long increased MF persists following cancer therapy, 2) how 
changes in MF associate with changes in mcBMD, 3) whether serum adiponectin can be 
used to measure changes in MF, and 4) how MF changes correspond to risk of incident 
fracture.  
Monitoring MF longitudinally with use of DECT can also become a significant 
area of research for investigators using MF as an early biomarker for osteoporosis.  
Monitoring the natural progression of red to yellow marrow as one ages could be used 
to alert healthcare providers if marrow composition is excessive for a given skeletal site.    
Another future application of the work in this dissertation is monitoring the 
skeletal-wide heterogeneity of cancellous bone to identify sites with an unusually higher 
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rate of bone loss.  Whole body DECT may able to create a predictive model to estimate 
what the average value of a certain skeletal site should be, compared to the rest of the 
skeleton.  Deviations from the predictive model in individual patients could highlight 
areas where local disease might be present.    
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7. APPENDIX 
7.1. Further investigation into functional heterogeneity using Dual Isotope micro-
PET/CT 
The following sections describe a study that can be used as a future direction of 
skeletal heterogeneity in terms of the bone mineral matrix, marrow composition, and 
the balance of bone remodeling.  The structural changes, such as those seen in the 
micro-CT studies above, reflect functional changes that can be measured through 
functional imaging (e.g. PET).   
Skeletal damage and response to treatments are regionally variable [12, 117, 
118], however, published reports have investigated only specific bone regions and fail to 
take a comprehensive approach. Our recent mouse micro-computed tomography 
(micro-CT) study revealed the potential for anatomical heterogeneity in the whole 
skeleton [119].  Other non-invasive options for hematopoietic and skeletal assessment 
include measuring plasma concentrations of Flt-3 ligand [120] and 45Ca assays for bone 
remodeling [116]. However, these methods only provide a measure of global damage. 
Characterization of regional marrow and bone metabolism are required to understand 
local and global tissue environments and treatment responses with emphasis on regions 
at risk for the development of metastatic disease and pathologic fractures [121]. 
Advancing the care of cancer patients requires the development and validation 
of appropriate experimental systems to ensure that animal studies accurately simulate 
clinical applications of radiotherapy based on radiobiologically relevant dose selection 
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[67, 116]. Monitoring the local and systemic changes in bone remodeling and skeletal 
damage resulting from local radiation will be beneﬁcial for optimizing potential 
interventions proceeding cancer therapy. Furthermore, a recent study strongly supports 
bidirectional co-regulation of marrow and bone at the microenvironment level [122]. 
Thus, a comprehensive approach to understanding the integrated response of both 
marrow and bone tissue to radiation damage is necessary. Taking advantage of novel 
non-invasive micro-CT guided micro-positron emission tomography (PET) in a hybrid 
system and dual tracers (18F labeled fluoro-2-deoxy-2-D-glucose (FDG), 18F labeled 
sodium fluoride (NaF)), we investigated functional heterogeneity of the whole skeleton 
and then examined the early effects of a clinically relevant local radiation application on 
local and systemic marrow and bone in an in vivo longitudinal study. 
7.2. Methods and Materials  
Six 16 week-old healthy BALB/c female mice (19.7±1.8 g, Harlan Sprague Dawley, 
Inc., Madison, WI, USA) were used for this study. All rodents were kept in a standard 
vivarium and were fed regular mouse diet and water ad libitum. All mice were fasted for 
at least 1.5 hours before isotope injection. 
The XRad 320 Biological Irradiator (Precision X-Ray, Inc., North Branford, CT, 
USA) was used for all irradiation procedures. Under anesthesia (IP injection with 
ketamine/xynazine cocktail), a specially designed lead shield (4 mm thickness) was 
placed over the body, to limit exposure to only the hind limbs (Figure 7-1A). Total dose 
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delivered(16 Gy single fraction) and skeletal volume irradiated were equivalent to pelvic 
irradiation based on normalized total dose (NTD) [123] as previously described by Hui et 
al with details of verifications [67, 116]. 
 
Figure 7-1 (A) Shielding designed to deliver radiation to the hind limbs. (B) Schematic of 
the experimental design. Micro-PET/CT acquisition was performed serially with FDG and 
NaF before and after the radiation to the same mice. Mice were dissected on day 3 after 
the radiation. 
 
 111 
 
PET acquisition was performed serially on days -5 and +2 with FDG for marrow 
metabolism [124] and days -4 and +3 with NaF for bone metabolism [125] relative to 
radiation treatment in the same mice (B). The InveonTM (Siemens Medical Solutions, 
Knoxville, TN, USA) was used to scan the region from skull to tibia. The isotopes were 
injected intravenously via the tail vein. The mean dose of FDG and NaF in 100 μl solution 
were 18.9±1.6 and 18.8±2.7 MBq, respectively, and measured with an Atomlab 100 
(Biodex Medical, Shirley, NY, USA), that had been cross-calibrated with the scanner. The 
scan (list-mode data acquisition) was started at 30 minutes post-injection under 
anesthesia using the manufacture’s recommended acquisition settings. For scanning, 
anesthesia was maintained at 1.5-3% isoflurane in 1 l/min O2 via nose cone. During the 
scan, the mouse was monitored with a dedicated respiration monitor (BioVet, Spin 
Systems Pty Ltd., Brisbane, Australia). A dedicated warming pad and infrared 
thermometer were also used to maintain body temperature. Legs were taped to 
minimize the movement. 
The bone VOIs (volume of interest) were first drawn on the CT image and later 
exported to the PET image. VOIs were identified semi-automatically using the 
segmentation feature based on a 3D region-growing algorithm and manual modification 
to minimize variations. There are eight regions; skull, mandible, humerus, cervical spine, 
thoracic spine (5th-10th), lumbar spine (1st-3rd), femur and tibia (40 slices from knee 
joint). The activity concentrations in the PET image and blood activity concentrations 
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were corrected for radiotracer decay (109.77 minutes) back to the tracer injection time. 
Whole blood and plasma activities approached steady-state at 60 minutes after 
injection (FDG: [126], NaF: [127]). Thus, whole blood can be used as a surrogate for 
plasma activity. A recovery coefficient was not applied. The activity ratios of skeletal 
regions to blood were calculated as bone-to-blood ratios. There is no unit of uptake of 
tracer because the value is calculated as a ratio of bone uptake activity (kBq/ml) to 
blood activity (kBq/ml). Heterogeneity described varying uptake distribution of a tracer 
among skeletal sites in this study. 
7.3. Results 
Figure 7-2 shows whole body scans of FDG (A and B) and NaF (C and D) uptake 
before and after radiation, demonstrating functional heterogeneity and radiation effect.  
 113 
 
 
Figure 7-2. FDG uptake before(A) and after radiation(B). NaF uptake before radiation(C) 
and after radiation(D). Constant maximum and minimum intensities are set in the 
images for each tracer. (E) FDG uptake before (blue bars, p<0.0001) and after (red bars, 
p=0.0002) radiation is significantly different among bone regions. (F) NaF uptake before 
(blue bars, p<0.0001) and after (red bars, p=0.0003) radiation is significantly different. 
Star(*) indicates irradiated bony region. 
 
FDG and NaF uptake are significantly different among bone regions (blue bars in 
Figure 7-2 E and F, p<0.0001 for FDG and NaF). Cervical and lumbar vertebrae had the 
highest uptake in both FDG and in NaF, respectively. Tibia exhibited the lowest uptake 
of both. 
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Radiation exposure to the hind limbs was 16.98±1.58 Gy. Visually, there was 
differential tracer uptake (Figure 7-2). Quantitatively, the degree of uptake after 
radiation exposure differed among the regions (p=0.0002, Figure 7-2 E). Irradiated 
region, especially the tibia, demonstrated significantly reduced FDG uptake at 32% of 
pre-radiation levels. Thoracic vertebrae were higher and tibia was lower compared with 
an overall average reduction (p<0.01, Figure 7-2 E). Figure 7-3 A shows FDG uptake 
averaged over all bone regions, demonstrating that radiation decreased FDG uptake 
overall (p<0.0001) on day 2 after radiation. Despite individual variability, uptake after 
radiation was approximately 50% of pre-radiation levels (Figure 7-3 A). Figure 7-3 B 
shows the difference in FDG uptake of individual mice before and after radiation. All 
mice show a similar response pattern with high activity in the skull and spine but with 
large variations (coefficient of variation) between individuals. In contrast, radiation 
significantly suppressed metabolic activity in the entire skeleton in all subjects with 
minimal individual variation. 
Red bars in Figure 7-2 F show NaF uptake following radiation. In individual mice, 
the NaF uptake averaged over all regions increased by a factor of 2.2. The degree of 
uptake after radiation differed among the regions (p=0.0003, Figure 7-2). The mandible 
and skull exhibited less variation from the averaged value (p<0.01, Figure 7-2). The 
lumbar spine and the irradiated regions (i.e. femur and tibia) appeared to have higher 
variation (p<0.1, Figure 7-2). NaF uptake significantly increased among all the regions on 
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day 3 after radiation (p=0.0314, Figure 7-3 C). Individual variation in NaF uptake was 
greater than for FDG. Three mice exhibited large increases (>2.0); two mice had 
moderate increases, and one slightly decreased. The uptake trend was similar before 
and after radiation (Figure 7-3 D). 
 
Figure 7-3. Radiation response pattern on individual mouse marrow and bone 
metabolism. (A) Radiation decreases FDG uptake over all regions (p<0.0001) on day 2 
after radiation. (B) FDG uptake before and after radiation among eight different bone 
regions. (C) Radiation significantly increased NaF uptake among all the regions on day 3 
after the radiation (p=0.0314). (D) NaF uptake before and after radiation among the 
bony regions. Star(*) indicates irradiated bony region. 
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 FDG NaF 
Skeletal regions 
Ratio 
before/aft
er (day 2) 
radiation 
95% 
CI 
lowe
r 
95% 
CI 
upp
er 
Ratio 
before/af
ter (day 
3) 
radiation 
95% 
CI 
lowe
r 
95% 
CI 
uppe
r 
Skull 0.57 0.44 0.72 1.9‡ 1.0 3.6 
Mandible 0.53 0.42 0.68 1.9‡ 1.0 3.6 
Humerus 0.51 0.40 0.65 2.3 1.2 4.3 
Cervical 0.45 0.35 0.57 2.2 1.2 4.2 
Thoracic 0.63† 0.49 0.80 2.2 1.2 4.2 
Lumbar 0.55 0.43 0.71 2.4‖ 1.3 4.5 
*Femur 0.46 0.36 0.59 2.4‖ 1.3 4.5 
*Tibia 0.32† 0.25 0.42 2.4‖ 1.3 4.5 
Overall average 0.50 0.41 0.60 2.2 1.1 4.5 
Radiation effect to whole 
skeleton 
< 0.0001 0.0314 
Radiation x skeletal region 
interaction 
0.0002 0.0003 
 *Irradiated region. 
Model contrasts: 
†For FDG, thoracic spine had a higher ratio and tibia had a lower ratio compared to the 
overall average (p<0.01). 
‡ For NaF, mandible and skull had a lower ratio compared to the overall average 
(p<0.01). 
For NaF, lumbar spine, femur, and tibia had a marginally higher ratio compared to the 
overall average (p<0.1). 
 
Table 7-1. Estimated change due to radiation. FDG averaged over all regions is expected 
to decrease to 50% of its pre-radiation level. This effect varied by region, and was 
particularly low for the tibia, where post-radiation FDG was 32% of its pre-radiation 
level. The NaF level averaged over all regions is expected to increase by a factor of 2.2 
following radiation. However, this increase varied by region, from a factor of 1.9 in the 
skull and mandible to a factor of 2.4 in the femur and tibia. The wide confidence 
intervals are the result of variable effects seen in different mice (see 7-3 C). 
  
 117 
 
7.4. Discussion 
Longitudinal non-invasive functional imaging with dual isotope micro-PET/CT 
following local irradiation in BALB/c mice revealed regional heterogeneity in marrow 
and bone metabolic function. Regional changes in marrow metabolic and mineral 
remodeling with a concurrent abscopal effect early following radiation at a variety of 
sites were observed longitudinally. This is the first report to characterize functional 
heterogeneity and changes from medically relevant radiation exposure in the whole 
skeleton. The application of dual isotope strategies allowed monitoring both local and 
distant effects on the entire skeleton following targeted radiation, including the 
simultaneous functional assessment of two distinct but interdependent tissues (i.e. 
marrow and bone). This technique may permit investigations into the multi factorial 
communication pathways between the two active tissue components in skeletal 
metabolism. 
Heterogeneity in bone uptake by FDG and NaF indicates functional 
differentiation among skeletal regions, suggesting metabolic differences at distinct bone 
sites. This heterogeneity could be due to structural and functional differences [128, 
129]. A greater trabecular network and less marrow volume in the spinal bones may 
lead to greater cross sectional area with a consequently higher metabolic activity. 
Understanding regional functional differences in the skeleton may therefore be crucial 
for: a) mapping sections of the skeleton to identify the regions that are most affected by 
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disease or clinical intervention rather than random selection of skeletal regions to assay, 
b) beginning to understand the role that local and whole body skeletal environments 
may play while interacting with systemic endocrine and immune elements, and c) 
developing treatment plans and evaluating the resulting response to disease 
management that incorporate factors such as skeletal site and bone marrow 
composition. 
FDG and NaF uptake of the irradiated region were significantly affected by 
treatment in the current investigation. Radiation decreased FDG uptake, likely indicating 
decreased bone marrow metabolism since the absolute number of bone marrow cells 
and their activity may affect FDG uptake [124]. This is in conformity with our previous 
report of a significant reduction in bone marrow cellularity by day 3 after radiation [67].  
Radiation may also lead to long term impairment in skeletal structure and 
function. Our previously reported study found diminished bone structure in long-term 
follow up after radiation [116]. Furthermore, there are likely biochemical and physical 
interactions between the bone surface (namely quiescent osteoblasts) and the adjacent 
marrow which may influence the radiation effects [130]. Dual isotope micro-PET/CT 
could be a tool to develop a comprehensive understanding of radiation-induced effects 
on skeletal metabolism by investigating the temporal (short- and long-term) and spatial 
(local vs distant) effects of radiation on bone structure and function. 
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There are challenges to performing longitudinal studies in preclinical model. 
Repeated scans of the same animal impact anesthetic tolerance. Careful management of 
anesthetic delivery and plane of anesthesia are essential steps to maintain quality of 
data integrity. Damage to the tail vein due to repeated injections should be avoided by 
varying injection sites. Single time point evaluations and radiation doses may have 
demonstrated a small set of cytokines that are activated after radiation. Further studies 
with additional time points and radiation doses will clarify the role of other pro- and 
anti-inflammatory cytokines in skeletal damage. 
7.5. Conclusions 
Non-invasive longitudinal imaging with dual isotope micro-PET/CT is feasible and 
allows the investigation of simultaneous changes in marrow and bone metabolic 
function. This technique may be useful for monitoring local and distal skeletal sites in 
response to radiation injury. There appears to be some functional skeletal heterogeneity 
among marrow and bone tissues. We observed temporally-related longitudinal changes 
in marrow metabolic and mineral remodeling locally and systemically in response to 
local radiation injury.  
 
